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1.1 Satellite stem cells and skeletal muscle development  
 
Skeletal muscle is a complex and heterogeneous tissue serving several functions in the 
organism, including locomotion and thermoregulation. Its maintenance is critical to provide a 
good quality of life in healthy individuals. Skeletal muscle regeneration after an injury is 
provided mainly by a specific stem cell population residing underneath the basal lamina, the 
satellite stem cells. The term “satellite” refers to their location adjacent to the muscle fiber 
(Mauro 1961), as shown in Figure 1. Upon sensing damage, those cells exit from their 
quiescent state and start to proliferate and subsequently migrate in the injury site. In this 
stage, their differentiation towards a myogenic cell type will start. Once they reach the area of 
the muscle that was damaged, they will align and further differentiate in order to form new 
functional myofibers (Mauro 1961; Morgan and Partridge 2003; Tedesco, F. S., Dellavalle, 
A., Diaz-Manera, J., Messina, G., & Cossu 2010; Dumont et al. 2015). Satellite cell 
activation, proliferation and differentiation are summarized and schematized in Figure 1. The 
production of new muscle fibers after an insult recapitulates for the most part the process 
regulating skeletal muscle formation during embryogenesis, termed as myogenesis. 
 
 
Figure 1- Satellite cells activation upon injury. Satellite cells are subjected to asymmetric cell division, 
differentiation towards myocytes and subsequent fusion and further differentiation. They are responsible to 
muscle fiber turnover and recovery. At different stages different transcription factors regulate the differentiation 
towards new mature myofibers (from Tedesco et al., 2010). For a more detailed description of the transcription 
factors involved in myogenic differentiation, refer to Figure 2.  
 
As depicted in Figure 2, myogenesis is a complex process, requiring the tightly regulated 
expression of many genes to coordinate the different developmental phases that will guarantee 
the correct formation of the tissue (Chargé and Rudnicki 2004; Bentzinger, Wang, and 
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Rudnicki 2012). Among these genes, the most important are Pax3 and Pax7, paired box 
transcription factors that exert their function at a myogenic precursor level, and the myogenic 
regulatory factors (MRFs) MyoD, Myf5, myogenin (MyoG), and Mrf4 (sometimes referred to 
as Myf6). Pax3/7 are early lineage specification regulators, Myf5 and MyoD commit cells to 
the myogenic program and myogenin and Mrf4 are marker for terminal differentiation and 
required for myocytes fusion into myotubes (Tajbakhsh 2009; Bentzinger, Wang, and 
Rudnicki 2012). In mice, myogenesis takes place from embryonic stage 8.5/9 (E8.5/9) to E 
18.5 (Tajbakhsh 2009). At E8.5/9 paraxial mesoderm is segmented in somites from which the 
dermomyotome will originate (Aulehla and Pourquié 2010). Dermomyotome cells express 
Pax3 and Pax7, as well as low levels of Myf5.  As the organism develops, those cells 
(identified as muscle progenitors) from dermomyotome ventrolateral and dorsomedial 
sections give rise to the myotome, a primitive muscle structure containing cells expressing 
high levels of MyoD and Myf5 (Kiefer and Hauschka 2001). Muscle of the limbs originate 
from migrating cells of the hypaxial domain of the dermomyotome and the myotome. After 
they reach the limb buds those cells become myoblasts, then myocytes and after fusion will 
form multi-nucleated myotubes (Bentzinger, Wang, and Rudnicki 2012). In this phase, the 
functional but still immature muscle cells express a fetal form of myosin heavy chain, referred 
to as embryonic myosin heavy chain (eMHC) or myosin 3 (MYO3). A part of uncommitted 
skeletal muscle stem cells that took part in tissue development does not progress along with 
the rest, entering in a quiescent state and forming the satellite stem cell niche. Those cells 
maintain the expression of Pax7 (Buckingham et al. 2003; Tajbakhsh 2009; Bentzinger, 
Wang, and Rudnicki 2012). 
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Figure 2- Transcription factor hierarchy in myogenesis. A strict regulation of the expression of specific 
transcription factors guarantees the successful formation of myofibers. This process is partially recapitulated 
during muscle regeneration. Figure from Bentzinger, 2012 (Bentzinger, Wang, and Rudnicki 2012). 
1.2 Skeletal muscle regeneration 
 
The same transcription factors whose expression is observed during myogenesis are present 
also during muscle recovery (Tedesco, F. S., Dellavalle, A., Diaz-Manera, J., Messina, G., & 
Cossu 2010). Moreover, muscle stem cells in adult muscles retain their migratory capability 
and the ability to sense the environment (Webster et al. 2015).  
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Figure 3- Schematic representation of the different phases of skeletal muscle regeneration. Following injury, 
inflammatory cells will be recruited to the damaged region. This first phase is characterized by myofiber 
necrosis and tissue inflammation, as well as initial fibrosis. Satellite cells will start to proliferate at the beginning 
of the regeneration phase, while M2 (anti-inflammatory) macrophages will promote their differentiation. Other 
cell types as fibroblasts and fibro-adipogenic progenitors (FAPs) will start to remodel a temporary extra-cellular 
matric (ECM) that will be subjected to further refinement during the remodelling phase by the action of 
metalloproteinases (MMPs) (Figure from Mahdy 2018) (Mahdy 2018).  
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Skeletal muscle recovery, while being similar in respect to expression of the genes involved, 
presents some key differences from the embryonic myogenesis. Indeed, skeletal muscle 
regeneration after an injury can be divided into three stages: a degenerative phase, a 
regeneration phase and a final remodelling phase, as shown in Figure 3. Almost immediately 
after the injury, the damaged area will be subjected to myofiber degeneration with cell 
necrosis and inflammatory cells infiltration (Tidball and Villalta 2010) (Figure 4). Neutrophils 
are the first inflammatory cells recruited to the damaged sites, followed by monocytes that 
will convert into macrophages. Macrophages found in the skeletal muscle are usually divided 
in two types: M1 and M2 (Saclier, Cuvellier, et al. 2013; Ogle et al. 2016; Wynn and 
Vannella 2016). M1 macrophages are the first to appear. They are referred to as classically 
activated or pro-inflammatory since they release inflammatory cytokines as IL-1, IL-6 and 
TNF-α. These cells will start a first response to damage by phagocytosis of necrotic tissue and 
activation of others immune cell populations (Massimino et al. 1997; Cantini et al. 2002). In 
addition to these effects, they are capable to promote satellite cells proliferation through 
different molecular signaling pathways, secreting IL-6 (Saclier, Yacoub-Youssef, et al. 2013) 
or NF-κB (Bakkar et al. 2008). M2 macrophages, known as alternatively activated or anti-
inflammatory macrophages, are activated after M1 macrophages and exert an anti-
inflammatory effect on the recovering muscle. These cells terminate the inflammation and 
contribute to tissue remodelling and satellite-cell differentiation (Saclier, Yacoub-Youssef, et 
al. 2013). They produce TGF-β1, that promotes the synthesis of ECM components, such as 
fibronectin and collagen  (Zanotti et al. 2007). TGF-β also inhibits myoblast differentiation by 
suppressing the expression of MyoD and myogenin (Brennan et al. 1991; D. Liu, Black, and 
Derynck 2001).  
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Figure 4- Hematoxylin-eosin (HE) staining of uninjured, cardiotoxin or glycerol-damaged tibialis anterior 
(TA) muscle cross-sections. In this figure the structural changes between an uninjured, a cardiotoxin (CTX, B, 
D, F, H) and glycerol-treated (C, E, G, H) muscle are shown. To note the infiltration of monocytes at day 4 
(evident in the CTX model, B) and the presence of center-nucleated fibers (arrows) in both models at day seven, 
ten and fourteen after the damage procedure was administered. Scale bar: 50 µm (figure from Mahdy, 2014). 
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During the regeneration phase, satellite cells undergo activation, proliferation and 
differentiation towards myotubes as schematized in Figure 5. After having aligned along the 
direction of the future muscle fiber, myocytes fuse to form a new muscle cell (Morgan and 
Partridge 2003; Tedesco, F. S., Dellavalle, A., Diaz-Manera, J., Messina, G., & Cossu 2010). 
Those newly formed myofibers express an embryonic isoform of myosin heavy chain, the 
embryonic myosin heavy chain (eMHC) (Schiaffino et al. 1986; Murphy et al. 2011; Judson 
et al. 2013; McDonald et al. 2015; Kastenschmidt et al. 2019) and present their nuclei in a 
central position (Judson et al. 2013; McDonald et al. 2015; Arecco et al. 2016; Kastenschmidt 
et al. 2019).  Although Satellite cells are frequently considered to be the principal cell type 
involved in muscle regeneration, recently also other cell populations showed to be involved in 
the recovery, such as fibroadipogenic progenitors (FAPs). The FAPs proliferate during the 
regeneration phase and participate in the formation of the temporary ECM (Mahdy 2018), that 
will serve as scaffold for the correct formation of new muscle tissue. It was shown that the 
presence of a scaffold composed of newly deposited ECM and residual ECM can heavily 
influence the muscle regeneration, as the scaffold can affect the orientation of newly formed 
muscle fibers (Webster et al. 2015). Moreover, the temporary ECM provides some sort of 
structural stability to the muscle and diminishes the stress that could affect the remaining 
functioning part of the organ (Webster et al. 2015). On the other side, the fibrotic tissue 
forming this way does not generate new muscle fibers, and an excessive scarification can 
hinder the recovery (Mann et al. 2011; Garg, Corona, and Walters 2015; Delaney et al. 2017).  
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Figure 5- Schematic representation of a regenerating skeletal muscle fiber. (A) Normal muscle fiber with 
myonuclei (dark) and satellite stem cells (grey nuclei, white cytosol. Upon sensing damage to the muscle fiber 
(B), satellite cells proliferate and migrate in the interested area. At this stage they will start their differentiation. 
After they align along the direction of the future muscle fiber (C) they will further differentiate into myotubes, 
who will present transiently center-positioned nuclei (D) (figure from Morgan and Partridge, 2003) (Morgan and 
Partridge 2003). 
The final stage of muscle recovery is the remodeling phase, in which newly formed myotubes 
mature into myofibers and the ECM is remodeled by metalloproteinases (Laumonier and 
Menetrey 2016). In this phase, depending on the severity of the initial damage and overall the 
grade of success of the tissue regeneration, fibrosis and scar tissue formation can be observed 
(Laumonier and Menetrey 2016). Depending on the objective of the study, fibrosis, i.e. as 
excessive production of ECM proteins, might be either desired or considered as an obstacle. 
When studying muscle regeneration, its reduction or prevention is preferred, because scar 
tissue hinders the complete recovery of the skeletal muscle (Mann et al. 2011; Garg, Corona, 
and Walters 2015; Delaney et al. 2017). 
 
Although presented here as sequential, degeneration, regeneration and remodelling stages are 
not so clearly separated during skeletal muscle degeneration and recovery: they overlap and 
interplay, creating a complex environment from several points of view, like the number of cell 
populations involved, chemical signaling, mechanic stimuli and gene expression. Such 
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complexity, although being more and more understood, is still not resolved and needs further 
investigation. To do so, different in vivo models have been developed, and the selection of the 
most appropriate one is critical for the resolve of the biological questions posed.  
 
 
1.3 Skeletal muscle damage models 
 
In order to study muscle degeneration and recovery, several animal models have been 
developed (Arnold et al. 2007; McCarthy et al. 2011; Czerwinska et al. 2012; Iwata, Suzuki, 
and Wakabayashi 2013; Tiryakioglu et al. 2015; Hardy et al. 2016; Mahdy 2018). Their 
outcome can change greatly, and every model must be chosen carefully depending on which 
aspects are of interest for the researchers. Skeletal muscle damage models differ in the injury 
mechanism they exploit and in the type of damage caused, that can affect greatly the 
degeneration/regeneration kinetics of the tissue. A recent classification was presented by 
Mahdy (Mahdy 2018), as shown in Table 1. Mahdy organizes the different muscle damage 
models in three main categories, according to the nature of the method used to induce the 
damage: physical, chemicals induced, and ischemic injuries.  
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Table 1- Summary of the most used experimental models for skeletal muscle damage. The glycerol-induced 
muscle damage model, as the one chosen in this study, is highlighted among the methods based on chemical 
injuries (modified from Mahdy (Mahdy 2018)). 
 
Physical injuries can affect several muscle compartments and result in severe damage, but 
their reproducibility is low as they heavily rely on the operator ability. Also, physical methods 
promote a heavily fibrotic environment with scar tissue formation, that hinder a complete 
muscle recovery (Garg, Corona, and Walters 2015; Laumonier and Menetrey 2016). 
 
Ischemic injuries are performed by blocking and then subsequently reperfusing a major artery 
in the chosen muscle. This leads to myofiber death and severe inflammation, ultimately 
resulting in an impaired regeneration together with an enhanced fibrosis (Vignaud et al. 
2010). Its reproducibility is impaired by the time and the severity of blood flow restriction, 
that can directly affect the amount of tissue interested by the damage. Those are considered 
the major disadvantages of this practice in ethical and reproducibility terms (B. Carlson 
2008).  
 
Injection of myotoxins is the most diffused method (Chazaud 2016), due to its simplicity and 
reproducibility. Myotoxins can be divided in three categories: local anesthetics, biological 
toxins and chemicals. Of the first two categories, the most used compounds are bupivacaine 
and cardiotoxin (CTX), respectively. Bupivacaine injection causes the sarcoplasmic reticulum 
to dilate together with an accumulation of swollen mitochondria in the subsarcolemmal region 
(Politi et al. 2006), leading to the destruction of a large number of myofibers but without 
affecting the basal lamina nor the satellite cells (Akiyama, Kobayashi, and Nonaka 1992; 
Politi et al. 2006) and avoiding any ischemic damage. While this method is effectively 
triggering a degeneration/regeneration mechanism (B. Carlson 2008), the large volumes 
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needed for the injection (up to the 50% of the volume of the muscle treated) can induce 
accidental systemic effects. Cardiotoxin is isolated from snake venoms, and is one of the most 
common methods to cause muscle damage (Czerwinska et al. 2012; Webster et al. 2015). Is 
able to induce a severe injury to the muscle fibers without affecting the basal lamina 
(Czerwinska et al. 2012), to the point to leave a space previously occupied by the muscle 
fibers, used as a supporting structures for muscle regeneration, the so called “hollow fibers” 
(Webster et al. 2015). Cardiotoxin exerts its effect by causing a calcium influx in the 
myoplasm leading to mitochondrial swelling and disruption, resulting in fiber necrosis 
(Mahdy, Warita, and Hosaka 2016). Among the chemical-induced muscle damage models, 
only the glycerol injection has the ability to disrupt the basal lamina, and so to deprive the 
muscle of an extracellular structural component that can help its recovery (Webster et al. 
2016). Glycerol effects are linked to the ability of this substance to cause, in virtue of being 
highly hydrophilic, an osmotic shock to the myofiber. Its action has an effect also on other 
muscle elements, including the basal lamina (Kawai et al. 1990; Pisani et al. 2010; Mahdy et 
al. 2015). Muscles injured by glycerol injection are characterized by an ectopic infiltration of 
adipocytes and localized fibrosis (Lluís et al. 2001; Mahdy et al. 2015; Mahdy, Warita, and 
Hosaka 2016; Hardy et al. 2016). Moreover, muscles lacking membrane-associated proteins, 
like dysferlin and myoferlin, are more sensitive to glycerol damage (Demonbreun et al. 2014). 
This feature, along with the muscle cells deprivation of the interaction with extracellular-
matrix associated elements that can enhance tissue recovery (Murphy et al. 2011; Iwata, 
Suzuki, and Wakabayashi 2013; Webster et al. 2016), is typical of this model. Although the 
damage drawn onto the muscle tissue is extremely severe in the early phases, the organ is able 
to recover anyway (Arsic et al. 2004; Mahdy et al. 2015; Mahdy, Warita, and Hosaka 2016). 
For these reasons, glycerol-induced muscle damage can prove an interesting injury model for 
the study of muscle regeneration.  
 
 
1.4 The neuromuscular junction structure and function 
 
The neuromuscular junction (NMJ) is a highly specialized major subclass of chemical 
synapses of the mammalian nervous system, which function is critical for the efficient transfer 
of information between the lower motor neuron and skeletal muscle. The NMJ structure is 
tripartite, consisting in the presynaptic motor neuron, the postsynaptic muscle and the glial 
cells associated to the synapse, the Schwann cells (referred also as terminal Schwann cells, 
TSCs) (Campanari et al. 2016). The pre- and postsynapse are separated by a narrow space (50 
to 80 nm wide), the synaptic cleft (Figure 6A). In the postsynaptic region, the sarcolemma is 
folded, and on the crest of each of these folds nicotinic acetylcholine receptors (AChRs) are 
densely clustered. At the bottom of each fold, a region enriched in voltage-gated sodium 
channels is found (Flucher and Daniels 1989).  
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Figure 6- NMJ tripartite structure and the proteins involved in its development and maintenance. In (A) a 
scheme depicting the NMJ structure is shown, in (B) the different proteins leading to NMJ maturation, 
organization and maintenance are listed and show in respect to their association to each other. Figure from 
Campanari et al. (Campanari et al. 2016). 
The neuromuscular junction is localized at the end of the motoneuron, and it transmits the 
nerve signal to the muscle fiber. Every mature muscle fiber is innervated by a single NMJ 
(Krause 1863).  
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Figure 7- Transmission of the neural stimuli ending in muscle contraction. Acetylcholine (ACh) released 
into the synaptic cleft from the nerve terminal binds to its receptor (AChR), triggering the transient opening of 
the cation channel of the receptor (1) and the influx of small cations, that gives rise to a synaptic potential. This 
localized change in membrane potential leads to the activation of voltage-gated sodium channels, eliciting an 
action potential (2) that propagates along the myofiber. Once this stimulus reaches the T-tubules (transverse 
tubules, extensions of the muscle fiber membrane containing a large number of ion channels that reach into the 
center of the myofiber), voltage-dependent calcium channels open and trigger ryanodine receptors in the 
sarcoplasmic reticulum (SR) to release calcium ions (3). Calcium then binds to troponin (4), leading to the 
exposition of binding sites for myosin on the actin filament. Myosin is bound by adenosine diphosphate (ADP) 
and phosphate (Pi) and forms cross-bridges with actin. The subsequent release of ADP and Pi will generate the 
stroke that causes the sliding of the thin filament past the thick filament, resulting in muscle contraction (5).  
 
The neuromuscular transmission process is schematized in Figure 7. Its function mediates 
voluntary muscle contraction. For the neuromuscular impulse transmission, calcium influx 
upon with motor neuron action potential promotes the fusion of synaptic vesicles at the 
terminal of the motoneuron at specialized sites, called active zones. This mechanism leads to 
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secretion of acetylcholine (ACh) in the synaptic cleft, where it diffuses and binds to its 
receptors, localized in the postsynaptic region. This causes the opening of the AChRs ion 
channels, generating a current of several hundred nA and then a local depolarization of the 
myofiber around 40 mV, defined as the endplate potential (EPP) (Tintignac, Brenner, and 
Rüegg 2015). This induces the opening of voltage-gated sodium channels at the bottom of the 
synaptic folds, that will give rise to an ulterior muscle action potential. Once this action 
potential reaches the T tubule, a part of the sarcolemma that reaches into the center of the 
fiber and triggers the release of calcium ions from the sarcoplasmic reticulum. Calcium ions 
will bind to troponin, causing a conformational change filament and the tropomyosin to move 
and exposing the active sites on G actin filaments. Heads of myosin filaments will then bind 
to those sites, ultimately resulting in muscle contraction. ACh is subsequently degraded by 
acetylcholinesterase (AChE), an enzyme linked to the basal lamina in the synaptic cleft (as 
schematized in Figure 6). 
 
1.5 Neuromuscular junction development 
 
In order for the neuromuscular junction to form successfully, pre- and postsynaptic 
components have to interact during embryogenesis. The motor neuron reaches an already 
present AChR cluster on the muscle fiber, thus leading to NMJ maturation. Such 
specialization involves several molecular mechanisms, and although there is no clear 
consensus on the precise molecular pathway that organizes and leads neuromuscular junction 
formation and muscle innervation, some key factors have been identified (their organization 
and the NMJ site is schematized in Figure 6).  
 






Figure 8- Scheme depicting NMJ development.  In (A) is showed how the motoneuron, approaching the 
muscle fiber, leads to NMJ formation, in particular (B) by promoting AChR accumulation at the future 
postsynaptic site. In (C) the effect of agrin is schematized: upon its binding to MuSK it promotes MuSK 
phosphorylation, leading to its association with rapsyn and AChR accumulation. Figure modified from Sanes 
and Lichtman (Sanes and Lichtman 2001). 
 
Early studies highlighted how muscle basal lamina was implicated during NMJ regeneration 
and development, as it was providing termination signals for the developing nerve and AChR 
aggregation signals for the muscle fiber. In particular, NMJ formation was observed to be 
based on pre-existing postsynaptic differentiation before motor-axon connection to the muscle 
fiber (Braithwaite and Harris 1979): this mechanism was indicated as “pre-patterning”.  
Agrin, a protein able to promote AChRs aggregation under the nerve during embryogenesis 
was detected in 1990 by the McMahan group at Stanford University (McMahan 1990). This 
protein is secreted by the developing nerve in the muscle basal lamina, promoting local AChR 
clustering and muscle regeneration. Agrin exerts its action by binding its receptor, the low-
density lipoprotein receptor-related protein 4 (Lrp4), thus activating the muscle specific 
tyrosine kinase receptor (MuSK). Upon its phosphorylation, MuSK recruits rapsyn, a protein 
constitutively expressed in skeletal muscle cells and linked to AChR (Apel et al. 1997). The 
presence of rapsyn allows the recruitment at the NMJ site of more AChRs (Sanes and 
Lichtman 1999; 2001), leading to the final maturation of the postsynaptic structure. Amongst 
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other, the maintenance of the NMJ is mediated by the dystrophin-glycoprotein complex 
(DGC), a transmembrane complex linking the myofiber cytoskeleton to the basal lamina and 
the ECM. This developmental mechanism is schematized is Figure 8.  
Subsequent studies challenged this model, as it was reported that postsynaptic differentiation 
was possible also in absence of the nerve (Kummer et al. 2004) and agrin (Gautam et al. 
1996). In a review, Kummer et al. concluded that those studies highlighted the necessity to 
redefine the role of agrin during synaptogenesis, as its function as synaptogenesis inducer was 
questioned by recent findings (Kummer, Misgeld, and Sanes 2006). Those studies led to the 
consideration that, although agrin has an important role in NMJ development and 
stabilization, other mechanisms are thought to be involved during synaptogenesis as well. 
The current opinion is that synaptogenesis is regulated by two mechanisms, one based on pre-
patterning and an independent one (Burden 2011), as those two models are not mutually 
exclusive and postsynaptic differentiation has been observed also in absence of pre-patterning 
(N. Kim and Burden 2008). Although progress have been made in the understanding of the 
role of agrin (as stabilizer and inducer) and other molecules, as MuSK, during the 
synaptogenesis, there is still not a clear consensus on the precise mechanism that regulates 
this process, and further research is needed. 
 
1.6 Neuromuscular junction damage models 
 
Although animal models to specifically study neuromuscular junction degeneration and 
recovery have not been developed, NMJs have been studied in several conditions in which 
skeletal muscle is affected, from aging (Rudolf et al. 2014; Taetzsch, Valdez, and Tech 2019) 
to dystrophy (Rudolf, Deschenes, and Sandri 2016) to muscle damage models (Röder et al. 
2012; S. J. Pratt et al. 2013; S. J. P. Pratt et al. 2014; Tu et al. 2017; Haddix et al. 2018).  
The mdx mouse model is widely used as a paradigm for muscle dystrophy, as the ablation of 
the gene enabling dystrophin production leads to mice presenting overall weakened muscles. 
Moreover, this model is used as well in the study of endplate degeneration, as mdx mice  
NMJs showed a distinct fragmentation in their structure as depicted in Figure 9 (S. J. Pratt et 
al. 2013; S. J. P. Pratt et al. 2015). 
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Figure 9- NMJ fragmentation in a wild type (WT) and in a mdx mouse. The motoneuron is detected using an 
antibody against neurofilament (purple), the presynapse with one against synaptophysin (green) and the 
postsynapse by using a BTX coupled with a fluorophore. Is clear how the NMJ in the mdx mouse is fragmented 
respect to the healthy ones in the wild type. Scale bar: 10 μm. Figure from Pratt et al. (S. J. P. Pratt et al. 2015). 
Endplate degeneration has been studied in this model also together with muscle injury, 
usually performed with physical methods, as causing myofiber necrosis performing few cuts 
on the exposed muscle (Haddix et al. 2018), exerting an eccentric contraction on the tissue (S. 
J. P. Pratt et al. 2014), or by tourniquet injury (Tu et al. 2017). The NMJ in the mdx muscles 
appears fragmented, and when injured endplates appear smaller and even more disrupted. 
Although NMJs in those condition show signs of recovery, they will ultimately resume to 
their fragmented status (S. J. P. Pratt et al. 2014). Along with the mdx model, also the SOD1 
mouse has been investigating regarding NMJs status, showing NMJ fragmentation (Rizzuto et 
al. 2015; Sugita et al. 2016; Tremblay, Martineau, and Robitaille 2017; Martineau et al. 
2018).  
NMJ disruption and recovery has been observed also in models where the nerve was affected, 
by surgical procedure (nerve excision) (Gwyn and Aitken 1966; Bongers et al. 2013; B. M. 
Carlson 2014; Komatsu et al. 2018; H. Liu and Thompson 2019) or with the use of toxins for 
its inactivation (Fex et al. 1966; Duregotti et al. 2015).  
More recently, NMJ functionality has been also measured in a novel model of muscle atrophy 
(Deguise et al. 2020). Differently from what has been observed in the mdx mouse, in this 
model NMJs were denervated, but did not presented a fragmentation as severe. 
While NMJ development suggest an involvement of the basal lamina on endplate formation, 
no damage model focused on the disruption of this muscle compartment have never been 
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1.7 Tissue clearing methods 
 
The standard practice in histology has been to cut tissue samples in thin slices to study a 
specific structure and the presence of distinct molecules. This method has proven to be robust 
and efficient, but a major drawback resides in the fact that biological structures are inherently 
tri-dimensional: in order to obtain precise information several slices are needed from the same 
sample and a “reconstruction” of the 3D structure of interest has to be performed afterwards. 
Moreover, such reconstruction can be subject to mistakes both during the processing of 
sections (meaning during the slicing and immunohistochemical staining) and during data 
acquisition and analysis. Therefore, 3D pictures obtained with this method cannot be treated 
as a real images, but only as a virtual reconstruction, subjected to mistakes in data collection, 
analysis or interpretation.  
Recent technological advancements in the fields of microscopy and tissue handling promise to 
overcome these shortcomings of classical 2D-histology. First, the obtainment of tri-
dimensional data has become possible with current confocal and LightSheet microscopy 
techniques. Second, opaqueness of tissue, that has impaired penetration of light through 
biological samples, has been recently reduced by optical tissue clearing to enhance 
visualization of whole-mount specimens. Tissue opaqueness is due to two physical 
phenomena: light absorption (mainly due to the lipidic portion of the tissue) and light 
scattering, the latter caused by the different refracting indexes present within a complex 
structure as an organ. The classical classification, as depicted in Figure 10 (Silvestri et al. 
2016), of different tissue clearing protocols is based on the main physical mechanism that is 
used to achieve tissue transparency, and divides the different techniques in four groups: 
organic solvents, high-refractive index aqueous solutions, hyperhydrating solutions and tissue 
transformation protocols. Those methods also differ in their ability to clear different tissues, 
the possible alteration they can cause to the tissue macrostructure and their compatibility with 




Figure 10- Classification of clearing protocols. The most common taxonomy divides the different methods for 
tissue clearing in four groups, depending on which mechanism they applied to obtain tissue transparency. Figure 
from Silvestri, 2016 (Silvestri et al. 2016). 
 
Dating back to 1914, the organic solvent-based methods were the first to be developed, with 
Spalteholz’s method to substitute water within a fixed tissue sample with a higher refractive 
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index solution (Spalteholz 1914). More recent approaches along this line followed the same 
paradigm of dehydrate the fixed tissue and then incubate it in a high-refractive index solution, 
as done by Dodt et al. (Dodt et al. 2007), that used a combination of benzyl alcohol and 
benzyl benzoate (referred to as BABB) as index matching solution. Although successful, 
BABB quenches fluorescence emission after a brief time, so alternatives in terms of use 
combination of dehydrating agent and index-matching solution were needed. This led to the 
formulation of 3DISCO (as in “3D imaging of solvent clearing organs) (Ertürk et al. 2012), 
followed by iDISCO (Renier et al. 2014), uDISCO (Erturk et al. 2016) and FDISCO (Qi et al. 
2019), that achieved good results in terms of tissue transparency and fluorescence 
preservation, as shown in Figure 11. From the BABB protocol, a further improvement based 
on pH control and a different hydration agent was produced, referred to as FluoClearBABB 
(Schwarz et al. 2015). Notably, also the FDISCO protocol focused on pH control as an 
important factor to be monitored in order to preserve protein fluorescence. 
 
 
Figure 11- Representative figures of the results obtained with organic solvent-based tissue clearing 
protocols. Results on mouse brain transparency achieved with different organic solvent based methods (A, 
different methods as indicated in figure) and in the fluorescent signal preservation (B) of FDISCO respect to 
3DISCO protocol (B, methods as indicated in figure, EYFP as endogenous yellow fluorescent protein). Figure 
adapted from Qi et al., 2019. 
 
As highlighted from the findings on organic solvents-based clearing protocols, fluorescence 
maintenance can be difficult to achieve. For this reason, some methods aim to maintain the 
sample in an aqueous environment, that can preserve better fluorescent proteins. Several 
solutions have been used to obtain such results, including sucrose or fructose solution (the 
latter used in protocols as FRUIT (Hou et al. 2015) and SeeDB (Ke, Fujimoto, and Imai 
2013). Due to the high viscosity of those mixtures, some organic compound alternatives, such 
as thiodiethanol (TDE), have also been used.  
 
While the methods described previously act on increasing the refracting index of the solutions 
in which the biological sample is embedded, protocols based on hyperhydrating solutions aim 
to lower the refractive index of the sample itself. This is achieved through hyperhydrating the 
proteic portion of the sample and by removing the lipids. Lipid removal can be operated by 
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using glycerol combined with a detergent and proteins can be hyperhydrated with urea: those 
are the main components of the Scale method, from which ScaleS (that uses sorbitol instead 
of glycerol) and CUBIC were developed. In order to avoid the use of detergent as much as 
possible, ClearT method was used: the lipid removal phase is absent, while protein 
hyperhydration is performed using formamide aqueous solution.  
 
Lipid removal can greatly increase tissue transparency, but also leads to a decrease of the 
proteic portion that results in possible loss of biological information. Moreover, while the use 
of solvents for lipid removal can decrease the refractive index of proteins from n=1.55 down 
to n=1.48 (results achievable with the use of hyperhydrating solutions as well), urea can act as 
a denaturing agent and so eliminate useful epitopes that can normally be exploited in 
immunohistochemistry procedures (Silvestri et al. 2016). To avoid the loss of protein and 
useful epitopes, tissue transforming techniques were developed: with those methods the 
proteins are stabilized by being cross-linked in a gel mesh. In this way the biological and 
structural identity of the sample is preserved. The first method of this kind was CLARITY, 
which used a polyacrylamide gel where proteins where cross-linked by paraformaldehyde 
(Chung et al. 2013; S. Y. Kim, Chung, and Deisseroth 2013; Tomer et al. 2014). This 
stabilization allows the use of strong detergents, like SDS, to remove the lipids. Subsequently, 
the sample is incubated in a refractive index-matching solution prior to imaging to achieve 
transparency. The lipid removal phase can be speeded up or increased in efficiency by using 
electrophoresis or higher incubation temperatures, although those procedures have to be 
conducted carefully as they can lead to sample damage. A scheme depicting the pipeline used 
for CLARITY is shown in Figure 12. 
 
 
Figure 12- CLARITY pipeline for a mouse brain. The tissue sample is perfused with a formaldehyde and 
acrylamide solution containing the thermal initiator as well. After the polymerization, the sample will be 
embedded in a meshwork of fibers preserving its structural and biological identity. A membrane lipid removal 
phase (passive or with the use of an electrophoretic chamber, ETC) follows to achieve tissue transparency. The 
resulting sample will be then labelled and imaged with light microscopy. To note that the data analysis and 
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management phase as to be taken into account, as the volume of sheer data obtained can go from few Gb to ~1 
Tb: a dedicated virtual infrastructure for data handling, segmentation and storage could be necessary. Image 
from Tomer et al. (Tomer et al. 2014). 
 
As described, many different tissue clearing methods have been developed, each one 
addressing several issues: organic solvent methods focus on achieving a high tissue 
transparency, but can be harsh for the survival of the fluorescence signal and on the 
microscope mechanical components coming in contact with them, as well as causing 
shrinkage of the sample in some cases (that can be considered a disadvantage to be avoided 
because is a tissue deformation or, as in case of some DISCO protocols, an desirable feature 
because it can allow imaging techniques that can have size-related limitations, as LightSheet 
or Digital LightSheet microscopy); methods based on the use of high RI aqueous solutions 
achieved a good fluorescence preservation, but are not able to achieve great tissue 
transparency; hyperhydrating solutions address tissue transparency and signal preservation 
equally, but the loss in biological information is hard to quantify; tissue transforming 
techniques are efficient, but are time-expensive and complex, has they need a tight control on 
several different parameters at the same time. In the end, a tissue clearing method has to be 
selected in virtue of its specific application, considering which structure or epitope is of 
interest and how it is possible to analyze it. In the specific case of this study, NMJ structure 
was investigated along with the presence of eMHC in muscle fiber using a fluorophore-
conjugated marker for AChR, α-bungarotoxin (αBGT), and an anti-eMHC antibody staining, 
respectively. For this reason, the MYOCLEAR protocol was developed in-house (Williams et 
al. 2019). Derived from the CLARITY protocol, MYOCLEAR is based on tissue embedding 
in an acrylamide hydrogel and applies a gentler detergent treatment than in CLARITY. These 
differences were necessary, since CLARITY is not compatible with the use of αBGT. As 
depicted in Figure 13, MYOCLEAR allowed penetration of mouse diaphragm and EDL 
murine muscle up to a depth of 1200 μm and the total visualization and segmentation of 
NMJs in such muscle.  
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Figure 13- Results on NMJs visualization and segmentation in a murine EDL muscle with MYOCLEAR. 
EDL muscles from wild type (wt) and mdx mice were cleared using the MYOCLEAR protocol and then stained 
with BGT linked to a fluorophore to study postsynapse number, position, shape and structure. NMJs were 
successfully identified through the entire EDL (A,B) and their structure was clearly conserved, with mdx NMJs 
presenting the fragmentation as expected ( A’, B’). When parameters describing NMJs structure were measured 
from different areas of the same muscle, and heterogeneity was found (C, E). Figure modified from Willliams et 
al. (Williams et al. 2019). 
 
1.8 Adipose-derived mesenchymal stem cells (ASCs) and their 
therapeutic applications  
 
Currently, several stem-cell based therapies are being tested as possible treatment for 
enhancing muscle regeneration. Different stem-cell sources are being considered for possible 
clinical application, including muscle-derived stem cells, mesangioblasts, muscle progenitor 
cells, interstitial cells and mesenchymal/stromal cells (Gois Beghini et al. 2019). This last 
group comprises the adipose-derived mesenchymal stem cells (ASCs), that present several 
interesting advantages compared to other sources: ASCs are immune-privileged, readily 
accessible from lipoaspirates and relatively easy to isolate and expand in vitro (Kern et al. 
2006; Torres-Torrillas et al. 2019). This last feature also allows for their accurate 
characterization and production following the good manufacturing practices. They have 
proven to be interesting for regenerative therapy applications in virtue of two characteristics: 
their differentiation potential and their trophic effects on other cell types. Even if ASCs are of 
mesodermal origin, they can be differentiated in cells from ectodermal, mesodermal and 
endodermal origin (Timper et al. 2006; Radtke et al. 2009; Deshpande, Grayson, and Spector 
2015; Si et al. 2019) (the specific cell types obtained are schematized in Figure 14). 




Figure 14- Scheme showing the different cell types that could be obtained by adipose-derived 
mesenchymal stem cells. Figure from Si, 2019 (Si et al. 2019).  
 
It is still unclear, if for a possible therapeutic application in the treatment of neuromuscular 
disorder a systemic administration has to be preferred over a local injection in the interested 
site. A local injection can improve cell engraftment in the affected area, but could be difficult 
in diseases where large parts of the tissue or different organs are affected, as it is for most of 
neuromuscular disorders (Gois Beghini et al. 2019). A systemic application can lead to the 
entrapment of most of the cells injected in specific organs as lungs and liver (Gois Beghini et 
al. 2019), but, on the other hand, several studies suggest that one of the principal function of 
stem cell based therapies is linked to their modulatory capability on cellular signaling rather 
than to their integration in the affected tissue (Law and Chaudhuri 2013; Gorecka et al. 2018; 
Boldyreva et al. 2019; Mitchell et al. 2019; Torres-Torrillas et al. 2019; Figliolini et al. 2020). 
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2. Aims of the study 
 
This dissertation has three aims:  
 
i) the investigation of skeletal muscle regeneration upon damage in an in vivo model, 
considering its sarcomeric components and the common indicators of damage, as 
muscle cells necrosis and fibrotic tissue deposition, together with the presence of 
markers associated with muscle regeneration as center-nucleated myofibers (CNFs) 
and cytosolic expression of eMHC.  
 
ii) the characterization of NMJ disruption and recovery in such muscle damage model, 
obtained by analyzing the pre- and postsynaptic compartments.  
 
iii) the study of the effects of stem cell application with respect to muscle and synapse 
recovery.  
 
In addition, this study focuses on the possible application of the MYOCLEAR tissue clearing 
protocol on glycerol-injected muscle in order to study muscle regeneration and NMJs in a 
three-dimensional aspect, providing some interesting, although preliminary, insights. 
 
Regarding the first point, a glycerol-induced muscle damage model was selected among those 
available. This choice was based on two characteristic effects of glycerol on the muscle, 
namely its capability to destroy the basal lamina and its reproducibility. While most studies 
on glycerol-induced muscle damage model use quantities of 50-100 µl of glycerol solution at 
different concentrations (most commonly 50% in saline solution) per muscle treated, usually 
gastrocnemius or tibialis anterior (TA) muscles (Lluís et al. 2001; Mahdy et al. 2015; Mahdy 
2018). Similar protocols are applied to induce rhabdomyolysis in order to study acute kidney 
injury (Korrapati, Shaner, and Schnellmann 2012; Huang et al. 2018; Reis et al. 2019). Since 
the interest of this study resides more into investigating skeletal muscle and synapse 
regeneration, a milder approach was chosen. One group reported that a dose of 25 µl of 50% 
glycerol solution (in saline) per TA muscle is able to cause a limited damage with adipocyte 
infiltration, necrosis and fibrosis (Arsic et al. 2004). Indeed, a similar quantity was used 
(20µl) in this study. With this study, the possibility to efficiently trigger a cycle of muscle 
degeneration and regeneration was tested. The use of smaller glycerol doses could result 
advantageous, as it could lead to better animal condition during the experiments and study 
reproducibility. 
 
Moreover, as NMJ status was usually assessed in genetic models or after denervation, the pre- 
and postsynaptic compartment of the motor endplate where monitored, in order to study 
eventual NMJ disruption and recovery. Endplate degeneration and regeneration, while being 
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extensively studied in other animal models, have never been investigated in condition where 
the basal lamina was directly damaged, as happens in glycerol-induced injuries. 
 
After having successfully characterized the damage model, ASCs therapeutic effects were 
tested. Thanks to the precious collaboration with professor K. Bieback, this study was able to 
test their systemic application to the glycerol-induced muscle damage model. ASCs are 
immuneprivileged and, since using lipoaspirates as source, easy to isolate and ethically 
available. For those reasons, ASCs and ASCs-derived products were evaluated as good 
candidates for possible therapeutic application in several treatments. In this study, human 
ASCs were administered systemically shortly after the glycerol injection in the TA was 
performed. Then, similar timepoints to the ones at which the damage model was monitored 
were chosen, along with all the markers used. This approach made possible to analyze muscle 
fiber necrosis, tissue fibrosis, muscle cells structure preservation and their regenerative state. 
The size and number of muscle fibers were measured as well. The same analysis and 
quantification performed for characterizing NMJ disruption and regeneration in the glycerol-
induced muscle damage model were performed also in the animals were ASC treatment was 
applied, with the exception of one of the time points used to characterize the model was not 
repeated in the ASC treatment, as it did not provide interesting findings (the day eight after 
the injection).  
 
The comparison between the glycerol-induced muscle damage model and the muscles that 
were subjected to the ASCs treatment would provide important information on their possible 
application in enhancing muscle recovery. Moreover, the focus on NMJ in such model and 
treatment is a complete novelty, as NMJ status and structure have never been observed before 
in this experimental condition. This can allow the researcher to obtain new insights not only 
on the muscle capability to regenerate, but also on the NMJ recovery.  
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3. Animals, materials and methods 
 
3.1 Animal experiments 
 
All animal experiments were approved by the local authority (Regierungspräsidium 
Nordbaden, Karlsruhe/Germany in agreement with EU guideline 2010/63/EU; license G-
139/18) and conducted in accordance with the German Animal Protection Law. To induced 
damage to the skeletal muscle, 20µl of 50% glycerol solution diluted in physiological saline 
were administered in the tibialis anterior (TA) muscle of two months old C57BL6 female 
mice, previously anesthetized. The same volume of saline solution was injected 
contralaterally as a sham. Foot contraction was used to determine if the injection was 
performed correctly (as shown in Figure 15), as it appeared few seconds after the glycerol 
injection. While still anesthetized, mice were also treated with painkillers and monitored up to 
6 hours after the procedure. Subcutaneous injections of 500 μl of saline solution were 
administered every hour to avoid dehydration, while the animals were kept in a heating 
chamber at 37°C in order to avoid hypothermia. Once the animals showed sign of recovery, 
they were transferred to normal cages. Muscles dissected from animals that, after injection, 
did not present any contraction were also lacking any sign of damage at early phase (three 
days after the treatment). For this reason, in such animals the procedure was evaluated as 
unsuccessful and they were not considered in further analysis. Notably, this hindlimb 
contraction lasted around 10 minutes after the glycerol injection, not hindering the mouse 
motility. The animals in which the injection was successful were euthanized by cervical 
dislocation three, five, eight, or eleven days after the procedure and the muscles dissected.  
 




Figure 15-Successful glycerol injection in the tibialis anterior leads hindlimb contraction. In the upper 
panel (A), mice hindlimbs are showed before the treatment, in the lower panel (B) the same mice are showed 
less than a minute after 50% glycerol solution (right hindlimb) or saline (left hindlimb) injection. The 
contraction in the glycerol-treated limb is evident. 
 
Where ASCs were applied, 1 million cells diluted in 100 µl of sterile PBS where injected via 
tail vein directly after glycerol treatment, whose was administered as previously described. In 
this case, animals were euthanized by cervical dislocation and dissected three, five, and 
eleven days after the injection. At least three animals for each timepoint and condition 
(glycerol and ASC with glycerol) were analyzed. A scheme of the experimental design is 
shown in Figure 16. 
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Figure 16- Scheme of the experimental design for the glycerol-induced muscle damage model. The days 
indicated start from the glycerol injection day (Day 0). 20 μl of 50% glycerol solution in saline solution were 
injected intra-muscle (i.m.). When adipose-derived stem cells (ASCs) treatment was applied, 1*106 cells 
resuspended in 100 μl of sterile PBS were systemically applied via tail vein (t. v.) soon after the glycerol 
injection was performed.  Following dissection (Sample collection), TA muscles were snap-frozen in liquid 
nitrogen and embedded in OCT. Soon after cryosections from those muscles were obtained and subjected to 
immunofluorescence (IF) analysis in order to quantify both muscle damage and its recovery, along with the 
status of the endplates. When glycerol injection without the stem cell treatment was analyzed, samples were 
collected three, five, eight and eleven days after the injection. Where ASCs were applied, the days considered for 
sample collection were three, five and eleven days after the injection. 
 
3.2 Adipose-derived mesenchymal stem cells (ASCs) 
 
ASCs were kindly provided by Prof. K. Bieback’s group, with the help from Daniela Nardozi 
(Prof. N. Gretz’s group) for their expansion and transport to the animal facility. ASCs were 
isolated from adult adipose tissue obtained from lipoaspirates of healthy donors, after 
obtained informed consent (Mannheim Ethics Commission II vote numbers 2010-262 N-MA, 
2009-210 N-MA, 49/05 and 48/05), as described before (Bieback et al. 2012). Briefly, the 
lipoaspirate was washed with sterile PBS to remove cellular debris and red blood cells and 
digested with 0.15 % w/v collagenase type I (Sigma-Aldrich) for 45 min at 37 °C. After 
washing, the pellet was resuspended in medium (DMEM low glucose, 10 % human AB 
serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 4 mM L-glutamine), plated and 
incubated overnight at 37 °C, 5 % CO2. After one day, the non-adherent and red blood cells 
were removed. Expanded cells were characterized regarding their proliferation capacity, 
immune phenotype, and adipo- and osteogenic differentiation potential, as described 
previously (Bieback et al. 2012). Before injection, ASCs were seeded at 750 ASC/cm2 and 
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expanded. On injection days, ASCs were trypsinized for 5 min at 37 °C and washed once with 
medium. The ASC pellet was then resuspended in sterile PBS at a concentration of 1 x 107 
cells / ml shortly before the injection. 
 
3.3 Immunofluorescence analysis 
 
Immediately after dissection, tibialis anterior (TA) muscles were covered with a thin layer of 
Frozen Section Compound (Leica) and frozen on liquid nitrogen. Transverse cryosections of 
15 – 20 µm thickness were produced using a Leica CM1950 cryostat, and then positioned 
carefully on glass microscope slides (Thermo Scientific) and subsequently immunostained for 
epitope detection. For immunohistochemical analysis, antibodies against specific antigens 
coupled directly to fluorescent dyes or with the use of fluorophore-coupled secondary 
antibodies and dyes. Cryosections were permeabilized with 0.1 % TritonX-100 / PBS for 10 
minutes at room temperature and, after three washing steps in PBS (5 minutes each), 
incubated with 2 % BSA / PBS for two hours to avoid unspecific binding of primary 
antibodies. Sections were then incubated overnight at + 4 °C with primary antibodies diluted 
in 2 % BSA / PBS. After three washing steps in 2 % BSA / PBS, sections were incubated with 
the secondary antibodies / dyes / toxins in 2 % BSA / PBS for three hours at room 
temperature and in the darkness. Antibodies, dyes, and dilution rates are listed in Table 3. 
Subsequently, after 15 minutes incubation with DAPI (Sigma) in 2 % BSA / PBS and three 
more washing steps with PBS (5 minutes each), glass slides were left to briefly dry and then 
mounted in Mowiol. The samples were then analyzed at the confocal microscope the day 
after. On the following day, images were taken using a Leica TCS SP8 microscope equipped 
with 405 nm, 488 nm, 555 nm, and 633 nm lasers, and Leica HC PLAN APO 20x/0.75 IMM 
CORR CS2 objective and at z-steps of 3 µm. For every sample, three to five entire 
cryosections from the central portion of the muscle at an intersection interval of roughly 200 
µm were visualized. Where ASCs were analyzed, they were immunostained with a slightly 
different protocol than the one used for TA muscles cryosections. Cells on Eppendorf 8 
chamber cell imaging slides were briefly fixed with 2% PFA / PBS and then permeabilized 
with 0.1 % TritonX-100 / PBS for 5 minutes at room temperature and, after three washing 
steps in PBS (5 minutes each), incubated with 2 % BSA / PBS for one hour to avoid 
unspecific binding of primary antibodies. The cells were subsequently incubated overnight at 
4 °C with the primary antibody diluted in 2 % BSA / PBS. After three washing steps in 2 % 
BSA / PBS cells were incubated with the secondary antibody and DAPI diluted in 2 % BSA / 
PBS for 45 minutes and in the darkness. After three more washing steps with PBS and one 
with ddH2O, the slides were mounted in Mowiol and analyzed using the same microscope 
and objective used for the muscle cryosections. As for the muscle cryosections, antibodies, 
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Primary antibody Company Catalog number Lot number 
Dilution 
rate 
Dystrophin antibody Invitrogen PA 1-21011 TK2665551J 1:200 
Myosin 3 antibody Biorbyt orb385438 RBQ34 1:100 
VAChT Synaptic Systems 139 03 2-44 1:500 
Collagen type I antibody Rockland 600-401-103-0.1 40681 1:500 
Recombinant Anti-Ku80 
antibody [EPR3468] 
Abcam GR3216586-3 ab80592 1:300 
Table 2- Primary antibodies used for immunofluorescence analysis. Dilution rates refer to the original 





Company Catalog number Lot number 
Dilution 
rate 
Donkey anti-Rabbit IgG 
(H+L) Highly Cross-
Adsorbed Secondary 
Antibody, Alexa Fluor™ 
488 
Thermo Fisher A-21206 176375 1:500 
Donkey anti-Rabbit IgG 
(H+L) Highly Cross-
Adsorbed Secondary 
Antibody, Alexa Fluor™ 
488 
Thermo Fisher A-21206 176375 1:500 
Goat anti-Rabbit IgG (H+L) 
Cross-Adsorbed 
ReadyProbes™ Secondary 
Antibody, Alexa Fluor 594 
Thermo Fisher R37117 1875978 1:500 
F(ab')2-Goat anti-Rabbit 
IgG (H+L) Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor™ 647 
Thermo Fisher A-21246 55002A 1:500 
Goat anti-Mouse IgG (H+L) 
Highly Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor™ 555 
Thermo Fisher A-21424 1802436 1:500 
Goat anti-Mouse IgG (H+L) 
Cross-Adsorbed Secondary 
Antibody, Alexa Fluor™ 
488 
Thermo Fisher A-11001 1834337 1:500 
α-Bungarotoxin, Alexa 
Fluor™ 488 conjugate 
Thermo Fisher B13422 1750294 1:500 
α-Bungarotoxin, Alexa 
Fluor™ 555 conjugate 
Thermo Fisher B35451 1880574 1:500 
Alexa Fluor™ 555 
Phalloidin 
Thermo Fisher A34055 1780358 1:500 
DAPI   
  
Sigma Aldrich D9542 28114320 1:1000 
Table 3- Secondary antibodies used for immunofluorescence analysis. Dilution rates refer to the original 
antibody or dye solution diluted in BSA 2%. 
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3.4 Tissue clearing and whole mount immunofluorescence 
 
The protocol used for skeletal muscles tissue clearing is the one already described by 
Williams et al. (Williams et al. 2019) and summarized in Figure 17. Briefly, freshly dissected 
TA muscles were incubated for less than 24 hours in freshly prepared 4% PFA (Roth) 
solution (in 1X PBS) and then transferred overnight in one 50 ml tube with 0,5% Tween-20 
(Sigma) 10µg/ml heparin (Sigma) solution (in 1X PBS) (PTwH) on a roller mixer at room 
temperature, to eliminate the residual PFA. The hydrogel embedding was then performed by 
incubating the sample with 40 ml of 4% acrylamide solution (in deionized water, as the salts 
contained in PBS could interfere with the gel polymerization) containing 2,5 g/l of VA-044 
activator as polymerization temperature-controlled catalyst. The tube used was a dark brown 
light-resistant 50 ml tube, necessary as light can interfere with the polymerization. After 
mixing, the tubes were incubated at 4°C on a roller mixer for five days. The hydrogel solution 
was then degassed using the Life Canvas EasyGel system: after being subjected to -90kPa 
pressure, the samples were flushed with nitrogen. Then the temperature was set to 37°C and 
the sample incubated for 4 hours while shaking. The muscles were then retrieved from the 
polymerized hydrogel and placed in 2ml tubes in PTwH on a roller mixer at room temperature 
to remove hydrogel excess. PTwH solution was frequently changed to guarantee the 
elimination of undesired residual hydrogel. 
 
 
Figure 17- Scheme representing the different phases of the MYOCLEAR protocol. Hydrogel embedding 
phase last from day 2 to day 7, staining from day 8 to day 15, RI matching from day 16 to 17. It has to be 
considered that, where needed, a second washing step and dye incubation step are needed if primary and 
secondary antibodies are used, increasing the procedure time by 7 days. 
 
The staining procedure of the hydrogel-embedded samples started immediately after, by 
incubating the sample in “Blocking and Permeabilization” solution (BnP, 10% PTwH, 0,5% 
Triton X-100, 1% DMSO, 6% BSA in 1X PBS) for two days. Then the samples were 
incubated with fresh BnP containing primary antibody solution for five days at 37°C, then 
washed for two days in fresh BnP and subsequently transferred in the secondary antibody/dye 
solution (in BnP) (for the Myosin 3 antibody,  the α-Bungarotoxin Alexa Fluor™ 555 
conjugate and the F(ab')2-Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, 
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Alexa Fluor™ 647 the dilution rates are as indicated in Table 3). The samples were then 
washed for two days with PTwH with frequent solution changes. 
Before imaging, the samples were incubated in distilled water for one day with frequent 
solution changes to remove any residual detergent presence, and then subjected to R.I. 
matching by being incubated for three days in 88% Glycerol solution whose R.I. was matched 
to a value of n=1.457. As it was observed that an exact n was necessary (differences from the 
value indicated as little as 0.002 can cause the images obtained to be blurry) the 88% glycerol 
solution was prepared and then exactly matched at the R.I. value desired, adding distilled 
water or glycerol. Another detail that has to be taken in account is the temperature at which 
the sample is kept before imaging, as it is suggested to store the sample in the same room 
where the microscope that will be used for imaging is kept, to avoid any temperature changes. 
 
3.5 Image analysis and semi-automated quantification  
 
Confocal images obtained from muscles cryosections were processed and analyzed using 
ImageJ (FIJI version). From maximum projections of the images, areas which showed the 
presence of mIgG or collagen I or actin were manually thresholded, areas selected and 
measured. The entire area of the cryosection was contoured by hand using the background 
signal. The areas where dystrophin-outlined cells were present were obtained from maximum 
projected confocal images to which was applied a median filter and then thresholded. 
Subsequently the “analyze particles” function of ImageJ was used (selecting 20 μm as lowest 
value and including holes). The image obtained was then measured. Muscle fibers, center-
nucleated fibers, and eMHC+ fibers were counted manually. Where myofiber cross-sectional 
area was measured, five patches of ten muscle fiber each were hand-contoured and their area 
measured for each cryosection analyzed. For each sample a minimum of three cryosections 
was processed and analyzed. NMJs, marked by AChR and VAChT expression, their shape 
and/or position with respect to muscle fibers, were analyzed and quantified manually. Signals 
for pre- and postsynapses obtained from three different cryosections per sample were 
analyzed. Details on the precise number of synapses analyzed are shown in Table 4.  In order 
to quantify the presence of ASCs, a different analysis was performed to quantify Ku80 
detection. DAPI signals corresponding to cell nuclei were thresholded and segmented. A 
selection created from those signals was then used to hand-segment the Ku80-positive signal, 




No ASCs ASCs 
Glycerol Saline Glycerol Saline 
3 
46.25 ± 4.33; 
185 (n=4) 
78.0 ± 20.6; 
312 (n=4) 
36.3 ± 13.1; 
101 (n=3) 
71.5 ± 11.79; 
213 (n=3) 
5 
67.3 ± 24.4; 
202 (n=3) 
94.3 ± 15.7; 
283 (n=3) 
88.5 ± 17.2; 
254 (n=3) 
76.0 ± 3.9; 
232 (n=3) 
8 
59.3 ± 10.7; 
178 (n=3) 




44.3 ± 15.8; 
133 (n=3) 
119.7 ± 19.2; 
359 (n=3) 
85.0 ± 8.1; 
255 (n=3) 
79.66 ± 7.17; 
239 (n=3) 
Table 4- Number of NMJs per experimental condition. Shown is mean ± SEM per muscle; number of NMJs 
found in total per condition (n indicates number of analyzed muscles per condition). 
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3.6 Statistical analysis and figures 
 
For statistical analysis, data were first screened for normality and homoscedasticity using 
Kolmogorov-Smirnov test and F-test. Mean and SD/SEM were calculated. Then, significance 
was assessed with Student’s t-test or Welch test. Data compilation was done in Microsoft 
Excel for Mac, plots were made using either Microsoft Excel for Mac or Graph Pad Prism. 










4.1 Glycerol injection leads to early necrosis and robust regeneration 
 
In order to observe the effects of glycerol injection in the tibialis anterior (TA) muscle, 20 μl 
of 50% glycerol (in saline solution) or saline (injected contralaterally as a sham procedure) 
were administered intramuscularly. The muscles were then harvested 18 hours, three, five, 
eight and eleven days after the procedure. Cryosections obtained from those muscles were 
then stained for different markers to study the muscle response to injury. Several parameters 
were evaluated to quantify how glycerol injection affects muscle degeneration and recovery. 
Firstly, necrosis and fibrosis were considered as they typically appear upon muscle injury. To 
evaluate muscle necrosis and general inflammatory state we observed the percentage of the 
area positive for mouse immunoglobulin type G (mIgG). While in healthy muscle, mIgG is 
normally located only in blood vessels and in the interstitial space, the compromised plasma 
membrane of damaged myofibers is expected to let serum proteins to be taken up into the 
cytosol (Iwata, Suzuki, and Wakabayashi 2013; Judson et al. 2013; Proto et al. 2015; Arecco 
et al. 2016; Rodrigues et al. 2016). Thus, while in healthy muscles the signal for mIgG was 
expected to be weak and concentrated mostly in blood vessels and interstitial space, damaged 
muscles were expected to show the presence of necrotic myofibers, whose cytosolic space 
should be positive for mIgG. For the same reason, those fibers should be subjected to leakage, 
losing f-actin from their cytosol. F-actin is the most abundant actin in myofibers 
(Prochniewicz Nakayama, Yanagida, and Oosawa 1983; Gokhin and Fowler 2011; 
Demonbreun et al. 2016) and is critical to myofiber functionality. Its presence was detected 
exploiting the ability of phalloidin toxin to bind it (Allen et al. 1996), so a fluorophore-
marked phalloidin was used. Muscle fibrosis, one of the early phenomena appearing upon 
muscle damage (Tedesco, F. S., Dellavalle, A., Diaz-Manera, J., Messina, G., & Cossu 2010; 
Garg, Corona, and Walters 2015; Webster et al. 2015) was evaluated by measuring the area 
that marked positive for the presence of collagen type I. Collagen type I is one of the most 
abundant protein in muscle extra-cellular matrix (ECM) (Huebner et al. 2008; Serrano and 
Muñoz-Cánoves 2010; Gillies and Lieber 2011; Feng et al. 2019). Together with those 
markers, also the presence of dystrophin was monitored, as it is a key element of the 
dystrophin-associated glycoprotein complex (DGC) and acts as a link between the 
cytoskeleton and the ECM. Its functionality ensures the coordination between those two 
muscle tissue elements and avoids the contraction-induced muscle damage (Biral et al. 2000). 
After immunostaining for mIgG, collagen I, dystrophin and eMHC (along with the marking of 
f-actin through phalloidin) confocal analysis of the TAs cryosections was performed. After 18 
hours from the injection, glycerol-injected muscles showed extensive damage, characterize by 
f-actin leakage and serum protein uptake as shown in Figure 18. Along with the loss of 
dystrophin, those parameters indicate a compromised cell membrane and overall loss of 
function in the areas affected. Moreover, cell nuclei not belonging to muscle fibers were 
observed in the areas affected by glycerol-induced injury, suggesting a cell infiltration. That 
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resembles what happens after an injury to the skeletal muscle, with fibroblast and monocyte 




Figure 18- Glycerol induced muscle damage is characterized by necrosis and loss of dystrophin and actin, 
followed by a transient expression of eMHC and the increase in center-nucleated fibers.  Representative 
optical sections of fluorescent signals as indicated (A), nuclear DAPI staining always shown in blue, mIgG in 
yellow, collagen I and eMHC in red, dystrophin in green, actin in grey. CTRL indicates muscle injected with 
saline three days post-injection, while the other panels show TA sections at three, five and eleven days after 
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glycerol treatment. (B) Quantitative analysis of section areas positive for fluorescence signals of either mIgG, 
collagen I, dystrophin, or actin, or number of eMHC-positive fibers, as a function of days p.i. Box-Whisker plots 
show all individual data points as dots, the extensions of upper and lower quartiles in the boxes, the medians as 
horizontal lines in the boxes, and maxima and minima as whiskers. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. (C-D) 
Quantitative analysis of fibers per muscle slice (C) or center-nucleated fibers (% of fiber number, D) as a 
function of days p.i. Box-Whisker plots show all individual data points as dots, the extensions of upper and 
lower quartiles in the boxes, the medians as horizontal lines in the boxes, and maxima and minima as whiskers. 
** p ≤ 0.01, *** p ≤ 0.001. Scale bar: 100 μm 
TA muscles dissected three, five, eight and eleven days after glycerol (or saline) injection 
were considered for the quantification of muscle damage and regeneration markers, as shown 
in Figure 18. Three days after the treatment, large areas of the muscle were interested by 
immunoglobulin infiltration, presence of necrotic myofibers, accumulation of fibrotic tissue 
and loss of functional markers as phalloidin and dystrophin, resembling closely an injured 
status already observed 18 hours after injection (Figure 19).  
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Figure 19- Glycerol injection leads to structural damage to muscle fibers within 18 hours from the 
treatment. After either glycerol or saline solution injection, TA muscles were harvested 18 hours after the 
treatment and snap-frozen. Subsequently, cryosections were obtained and stained with mouse immunoglobulin G 
antibody, phalloidin (both coupled with a fluorophore) and anti-dystrophin antibody.  Treated muscles (18 hrs 
p.i., on the right) show serum proteins uptake (mIgG) in the cytosolic space, indicating necrosis, along with loss 
of dystrophin and actin respect to the contralateral muscles (CTRL, on the left). Scale bar: 100μm. 
 
Moreover, the number of muscle fibers was significantly decreased (Figure 18C). In the 
following timepoints, five, eight and eleven days after the injection, these signs of muscle 
damage decreased and regeneration markers started to appear: between five and eight days 
post-injection a wave of eMHC expression was observed, along with a significant increase in 
CNFs and the return of the muscle fibers number back to the one counted in saline-injected 
samples. Both eMHC+ and CNFs fibers were present until eleven days after the injection, 
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while damage-related parameters returned to normal levels. This indicated that within eleven 
days from the treatment, although a strong initial damage with necrosis, fibrosis and loss of 
functional proteins, the muscle was able to regenerate efficiently. The remaining muscle 
fibers cross sectional area (CSA) was measured in order to detect any kind of change in the 
myofiber size (Table 5). No significant difference between the control and the glycerol-treated 
samples was detected at any timepoint, suggesting that the fibers surviving the glycerol 






Saline (control) Glycerol 
3 2010.5 ± 104.8 2136.5 ± 164.4 
5 1885.6 ± 290.3 1969.0 ± 312.1 
11 1934.6 ± 122.1 1963.1 ± 218.2 
Table 5- Cross-sectional area per fiber in µm2 per experimental condition. Shown is mean ± SEM (n=3 
mice). None of the values differed significantly from any other. 
 
Notably, as shown in Figure 20, the damage was not homogenous, probably due to the low 
volume of glycerol used. Both, damage-related (mIgG and collagen I presence and absence of 
actin and dystrophin) as well as regeneration-associated markers (eMHC) where localized in 
distinctive areas. After having characterized how a low-dose glycerol injection affects muscle 
destruction and subsequent recovery, the focus moved towards analyzing pre- and 
postsynaptic regions in order to characterize NMJ degeneration and regeneration. 
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Figure 20- Glycerol induced muscle damage is characterized by necrosis and loss of dystrophin and actin, 
followed by a transient expression of eMHC and the increase in center-nucleated fibers.  Representative 
optical sections of fluorescent signals as indicated, nuclear DAPI staining always shown in blue, mIgG in 
yellow, collagen I and eMHC in red, dystrophin in green, actin in grey. CTRL indicates muscle injected with 
saline three days post-injection, while the other panels show TA sections at three, five and eleven days after 
glycerol treatment. Scale bar: 500 μm 
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4.2 Glycerol injection leads to transient loss of presynapses 
 
In order to characterize the effect of glycerol-induced muscle damage on NMJs, TA muscles 
were injected with 50% glycerol solution or saline and samples were taken three, five, eight 
and eleven days after the injections. Cryosections were stained against nicotinic acetylcholine 
receptors (AChR) using fluorescent αBGT in order to identify postsynapses. Presynapses 
were analyzed by investigating the presence of vesicular acetylcholine transporter (VAChT), 
using anti-VAChT immunofluorescence staining. Analysis at the confocal microscope of 
treated samples showed that AChR+ signals were present at all time-points, indicating that the 
presence of postsynapses was largely retained throughout the entire experiment. On the other 
hand, many of the sites identified by AChR+ signals were negative for VAChT at three, five 
and eight days after glycerol injection. Further analysis showed that in glycerol-treated 
muscles the number of AChR+ sites was slightly, but not significantly, reduced compared to 
the ones counted in the muscles injected with saline. The only exception was at eleven days 
after the injection, where the number of postsynapses detected in the control was significantly 
higher than the one obtained from the treated muscles. 
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Figure 21-Glycerol treatment affects differently pre- and postsynapses. Representative images of the 
localization of AChR (in green) and VAChT (in red) and their overlay in TA muscle cross section (A) at 
different timepoints (The sham procedure three days after the injection indicated as sham, the other timepoints as 
in the amount of days post-injection (p.i.)). Scale bar: 100μm. Quantitative analysis of AChR+ sites (B) present 
per cryosection and percentage of how many of them were positive for VAChT as well (C). Shown is mean ± 
SEM (n = 3 muscles). * p ≤ 0.05, ** p ≤ 0.01. 
 
Although some features of the NMJs, such as volume and fragmentation, cannot be evaluated 
effectively from cryosections, a measure of the area of the post-synaptic sites was conducted. 
This showed that the measured postsynaptic sites areas were not altered by condition or day 
after treatment (Table 6).  





3 122.6 ± 38.6 203.5 ± 26.4 
5 158.0 ± 33.7 180.3 ± 33.8 
11 184.7 ± 20.3 158.2 ± 42.4 
Table 6- Areas of NMJs in µm2 per experimental condition. Shown is mean ± SEM (n=3). None of the values 
differed significantly from any other. 
 
As previously indicated, AChR+ sites were analyzed regarding the presence of VAChT as 
well, in order to quantify how many of the postsynapses detected presented also a signal 
associated with a presynaptic marker, and so could be assumed to indicate a functional NMJ. 
AChR-positive and VAChT-positive synapses were significantly less abundant in the 
glycerol-treated muscles three, five and eight days after the injection respect to the sham. 
(Figure 21C). Notably, postsynaptic but not presynaptic sites appeared also in areas that 
presented severe necrosis (Figure 22).  
 
These results show that glycerol lead to a reduction in the number of the postsynapses, that 
became significantly reduced at a latter timepoint (11 days p.i.) respect to the one measured in 
the muscle subjected to the sham. Moreover, the presynapses showed to be more sensitive to 
the glycerol treatment, showing a significant reduction respect to the control three, five and 
eight days after the injection. Overall, these results indicate that glycerol has a more 
detrimental effect on the presynapse than on the postsynapse. Although, while the former 
shows a recovering trend, the diminished number of the latter at eleven days after the 
treatment suggest that some postsynapses undergo to degradation several days after the 
muscle was subjected to the damage. 
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Figure 22- AChR+ VAChT- sites were identified in highly necrotic areas as well as in unaffected regions. 
Representative images AChR+ VAChT- NMJs. mIgG (in yellow), AChR (in green) and VAChT (in red) and 
their overlay in TA muscle cross section at different timepoints (indicated as in the amount of days post-injection 
(p.i.)). Postsynaptic sites were conserved in necrotic areas of the muscle as well as in those regions not interested 




4.3 Glycerol-induced muscle degeneration and recovery are altered by 
adipose-derived stem cells (ASCs) 
 
A further goal of this dissertation is to address the effect of stem cells, ASCs in particular, on 
muscle recovery after an insult. In order to do so, few minutes after intra-muscle injection of 
either saline or glycerol solution, ASCs were administered systemically via tail vein. Then, 
the same analysis performed for the characterization of the damage model were repeated on 
TAs cryosections harvested at three, five and eleven days after the injection. While the 
findings on the number of myofibers and on dystrophin and f-actin distribution resembled 
those obtained from samples not treated with ASCs (Figure 23), the data regarding mIgG, 
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collagen I, eMHC presence and the number of CNFs proved to be interestingly different from 
those collected from muscle treated only with glycerol (Figure 23, A-B). mIgG ad collagen I 
significantly increased at eleven days after the injection, while in the damage model at this 
timepoint their presence was comparable to the one detected in the controls.  
 
 
Figure 23- ASCs systemic application leads to mIgG infiltration, enhanced eMHC basal expression and 
increase in the center-nucleated fibers. Representative optical sections of fluorescent signals as indicated (A), 
nuclear DAPI staining always shown in blue, mIgG in yellow, collagen I and eMHC in red, dystrophin in green, 
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actin in grey. CTRL indicates muscle injected with saline three days post-injection, while the other panels show 
TA sections at three, five and eleven days after glycerol treatment. (B) Quantitative analysis of section areas 
positive for fluorescence signals of either mIgG, collagen I, dystrophin, or actin, or number of eMHC-positive 
fibers, as a function of days p.i. Box-Whisker plots show all individual data points as dots, the extensions of 
upper and lower quartiles in the boxes, the medians as horizontal lines in the boxes, and maxima and minima as 
whiskers. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. (C-D) Quantitative analysis of fibers per muscle slice (C) or 
center-nucleated fibers (% of fiber number, D) as a function of days p.i. Box-Whisker plots show all individual 
data points as dots, the extensions of upper and lower quartiles in the boxes, the medians as horizontal lines in 
the boxes, and maxima and minima as whiskers. ** p ≤ 0.01, *** p ≤ 0.001. Scale bar: 100μm 
 
As for the glycerol-induced muscle damage model, a measure of the myofiber CSA was 
performed (Table 7). The CSA did not change between the different days or condition, and no 
significant differences between the values was detected when compared to the measures on 





Saline + ASCs (control) Glycerol + ASCs 
3 1852.4 ± 64.6 2028.0 ± 209.5 
5 2234.0 ± 129.6 2075.5 ± 145.1 
11 1836.1 ± 132.5 1651.3 ± 59.2 
Table 7- Cross-sectional area per fiber in µm2 per experimental condition. Shown is mean ± SEM (n=3 
mice). None of the values differed significantly from any other. 
 
Notably, mIgG were identified in the extracellular space, indicating more likely an 
inflammatory state of the tissue then the presence of necrotic fibers, whose presence was not 
detected at that timepoint. Also, in terms of fibrosis, instead of detecting the deposition of scar 
tissue in specific areas as seen in the damage model, the increase in collagen I was located 
mostly along the borders of the muscle fibers. The presence of collagen I in such areas could 
be indicative of a more systemic inflammatory state, instead of a fibrotic area with large 
deposition of scar tissue as observed  in the absence of ASC. Together with the data obtained 
from the staining for mIgG presence, this can indicate the presence of a late-phase 
inflammatory status of the muscle. eMHC expression, although following a similar trend to 
the one observed in the damage model, was present also in the saline controls when stem cells 
were applied. Moreover, in the animals treated with glycerol and ASCs the percentage of 
center-nucleated fibers rose over time up to 71.4%±15.8% (mean ± SEM, n=3 samples) 
eleven days after the injection, while in the corresponding saline controls it remained at basal 
levels (0.6 % ± 0.7 %, mean ± SEM, n = 3 samples). These results lead to two observations: 
First, ASC application induces a late-phase inflammatory phase, as shown by the increased 
levels of mIgG and collagen I, indicating serum protein increase in the extracellular space and 
fibrosis respectively. Second, ASCs can enhance the regenerative process, leading to a 
prolonged muscle recovery phase, as shown by the high amount of CNFs and by the 
expression of eMHC in the controls where ASCs were applied. So, while a secondary 
inflammation, although limited and not indicating a severe damage condition as the one 
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observed three days after the treatment, is not desirable, a prolonged regenerative phase is a 




Figure 24- ASCs systemic application leads to mIgG infiltration, enhanced eMHC basal expression and 
increase in the center-nucleated fibers. Representative optical sections of fluorescent signals as indicated (A), 
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nuclear DAPI staining always shown in blue, mIgG in yellow, collagen I and eMHC in red, dystrophin in green, 
actin in grey. CTRL indicates muscle injected with saline three days post-injection, while the other panels show 
TA sections at three, five and eleven days after glycerol treatment. Scale bar: 500μm 
 
4.4 Adipose-derived mesenchymal stem cells (ASCs) treatment reduces the 
loss of presynapses in the glycerol damage model 
 
Next, the effects of ASCs in the kinetics of loss and recovery of NMJs were quantified. TA 
muscles cryosections from the animals treated with ASCs and then injected with glycerol or 
saline solution were investigated for the presence of AChR and VAChT and analyzed by 
confocal microscopy.  
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Figure 25- ASCs enhance recovery of presynapses at early stages, but such effect is not present at late time 
point. As soon as TA muscles were injected with either saline or 50% glycerol solution, mice were injected via 
tail-vein with ASCs. TA muscles were then harvested and immediately snap-frozen three, five or eleven days 
after the injection (days p.i.). After cryosectioning, muscle sections were stained with αBGT (marking AChR) 
and antibodies against VAChT to label post- and presynaptic portions of NMJs, respectively. Cryosections were 
then analyzed with confocal microscopy. (A) Representative images of fluorescence signals as indicated, AChR 
in green, VAChT in red, in overlay images yellow indicates the colocalization of both signals. Saline-injected 
muscles at 3 days p.i. indicated as CTRL, while the other panels show representative images from glycerol-
injected muscles at three, five, and eleven days post-injection. Scale bar: 100µm. (B-C) Quantitative analysis of 
AChR+ post-synaptic sites present per section (B) and of VAChT+ NMJs (as percentage of VAChT+ structure, 
C) as a function of days after the treatment. Shown is mean ± SEM (n = 3 muscles). * p ≤ 0.05, ** p ≤ 0.01. 
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The quantification of AChR+ sites did not show any difference between glycerol and saline 
injected muscles (Figure 25, B), though a reduction (not significant) of postsynapses was 
observed in glycerol treated muscles. Quantification of AChR+/VAChT+ sites showed an 
improved recovery at three and five days after the injection respect to the samples were ASCs 
were not applied. At those timepoints, the amount of AChR+/VAChT+ NMJs detected in 
glycerol treated muscles was 41.4% ± 17.3% and 48.1 % ± 7.2 % (mean ± SEM, n = 3 
muscles) at three and five days post-injection respectively, while where ASCs were applied 
they reached 65.1 % ± 10.3 % and 83.4 % ± 1.3 % (mean ± SEM, n = 3 muscles) at the same 
timepoints. On the other hand, these seemingly better regeneration was proven to be only 
temporary, as the values dropped to 57.3%±3.7% (mean ± SEM, n = 3 muscles) eleven days 
after the treatment with glycerol and ASCs instead of showing further recovery as it was 
observed in animals were only the damage procedure was applied (65.8%±16.9% (mean ± 
SEM, n = 3 muscles) AChR+/VAChT+ sites on day eleven).  
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Figure 26-Integration of systemically injected ASC into muscle is not detectable by immunofluorescence. 
Isolated human ASC and mouse TA muscle sections taken five days post injection of either saline or glycerol 
(indicated) were stained with DAPI and an anti-human Ku80 antibody against DNA and human nuclei, 
respectively. (A) Representative confocal micrographs showing fluorescence signals of DAPI and human Ku80 
in blue and green, respectively. (B) Quantitative analysis of the percentage of human Ku80+ signals found in 
DAPI+ nuclei. 
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Subsequently, the possible presence of ASCs was investigated within the muscles treated, to 
verify if their effect on the muscle and the NMJs was to be ascribed to their local presence or 
to indirect effects. In order to do that, ASCs in culture, and control muscles 5 days after the 
glycerol treatment (with or without the stem cell application) were stained for the detection of 
Ku80, a nuclear marker for hASCs (Koike et al. 1999). While in the ASCs the presence of 
Ku80+ cell nuclei was evident (Figure 26A), in the muscles such signals were absent. 
Moreover, when quantified (Figure 26B) the amount of Ku80+ cell nuclei present in the 
muscle not treated with ASCs was comparable to the values measured in the samples that 
were subjected to stem cell application. It has to be noted that, since ASCs were injected 
systemically, any effect linked to their human origin should be normalized when compared to 
the controls. In summary, systemic treatment with ASCs resulted in a transiently better 
recovery of the damaged skeletal muscle after the glycerol injection. However, these 
beneficial effects lasted only for the early timepoints (three and five days after the injection), 
as the number of functional sites at eleven days after the injection was comparable to the one 
measured in the muscles where only the damage was induced, without any stem cell infusion. 
Such beneficial, although temporary, effects on muscle regeneration cannot be ascribed to a 
direct effect of ASCs on skeletal muscle, as their presence was not detected at any of the 
timepoints considered. On the other hand, another theory could be that ASCs can exert their 
influence of muscle regeneration by a “long-range” mechanism, through the secretion of anti-
inflammatory substances as IL-6 (Wu et al. 2017). Such chemical species have been proven to 
promote an anti-inflammatory state (Belizário et al. 2016) that could explain the decrease in 
fibrosis and mIgG presence detected along with a more prominent muscle regeneration 
registered at 11 days p.i. Both those effect could be a direct consequence of a M2 macrophage 
activation, promoted in fact by molecules as IL-6 (Mahdy 2018). Although fascinating, such 
hypothesis would require further investigation both regarding the presence of specific 
molecules within the recovering muscle tissue and the macrophage activation. 
  
 
4.5 Tissue clearing for postsynapse structure and embryonic myosin heavy 
chain (eMHC) expression 
 
In order to investigate the postsynaptic structure preservation and eMHC expression in the 
glycerol damaged muscle, one glycerol-injected and one saline-injected TAs were dissected 
five days after the treatment and subjected to the MYOCLEAR tissue clearing procedure. 
Afterwards, whole-mount scan of the two muscles were performed in order to study the 
expression of eMHC in 3D and to investigate the postsynaptic structure in detail. In the 
control, as shown in Figure 27, the results obtained showed an overall conserved muscle 
fibers structure together with the presence of NMJs presenting the classical pretzel-shaped 
structure. eMHC expression was absent, with the only few signals detected to be ascribed to 
secondary antibody residue.  
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Figure 27- eMHC is not present in saline-injected muscles and postsynaptic structure is preserved. Five 
days after saline injection, TA muscle was dissected and cleared using the MYOCLEAR procedure and then 
immunostained with anti-eMHC antibody (subsequently coupled with a fluorophore-conjugated secondary 
antibody) and a fluorophore-conjugated α-BGT. (A) 3D images of saline-injected TAs. Autofluorescent 
background (Autofluo) signal in the 488 nm channel was used to highlight the muscle structure and is shown in 
green, eMHC in red and presence of AChR in white. No constitutive expression of eMHC was observed in this 
sample. Scale bar: 1 mm. (B) Magnification of the postsynaptic structures showed the preservation of their 
classical pretzel-like shape, without any sign of fragmentation. 
 
Once analyzed the control, the muscle who was injected with glycerol five days before 
dissection was investigated. As mentioned before, data from classical immunohistochemistry 
showed a peak in eMHC expression at this timepoint. As shown in Figure 28, those findings 
were confirmed from the whole mount three-dimensional scan of the glycerol treated muscle: 
eMHC presence was evident within the muscle, and seemed to be concentrated in the area 
were the injection site could be located (circular-shape wound, is clearly visible in the upper 
right and middle right panels). 
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Figure 28- eMHC expression in glycerol-injected TA, postsynaptic structure is preserved. Five days after 
glycerol injection, TA muscle was dissected and cleared using the MYOCLEAR procedure and then 
immunostained with anti-eMHC antibody (subsequently coupled with a fluorophore-conjugated secondary 
antibody) and a fluorophore-conjugated α-BGT. (A) 3D images of saline-injected TAs. Autofluorescent 
background (Autofluo) signal in the 488nm channel was used to highlight the muscle structure and is shown in 
green, eMHC in red and presence of AChR in white. Strong presence of eMHC was observed in this sample. 
Scale bar: 1mm. (B) Magnification of the postsynaptic structures showed the preservation of their classical 
pretzel-like shape, without any sign of fragmentation. 
 
Moreover, areas that were positive for eMHC did not presented a background autofluorescent 
signal as strong as those regions were eMHC was absent. Another interesting observation was 
that some fibers were only partially positive for eMHC presence, showing as a perfect 
example of biological information only obtainable by 3D microscopy. Moving forward to the 
NMJs, the postsynapses observed seemed unaffected by the degeneration/degeneration 
mechanism that were occurring in the muscle: none of the NMJs detected in the treated 
muscle was either fragmented, indicating a possible degeneration of the synapse, nor 
presented a button-like shape as newly developed synapse could have during their formation. 
This is clearly shown in Figure 29, were is possible to appreciate how the postsynapse 
structure is conserved three days after the glycerol treatment.  There are some differences in 
the cell nuclei presence and in the mIgG distribution. In the control muscle seems to be an 
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enrichment in cell nuclei, with some of those colocalizing in the NMJs region, while the 
damaged muscle does not show many cell nuclei near the NMJs. The mIgG presence in the 
control is detected mainly in those areas that, by their shape, position and size, can be 
identified as blood vessel, while in the damaged muscle its presence is more ubiquitous. 
Although interesting, those findings could not be confirmed due to a lack of available 
samples, but suggest that the glycerol treatment leans more to a “all or nothing” damage 
mechanism in regards to NMJs: instead of having then to degenerate, showing fragmentation, 
it leads to a complete disruption of the synapse, that is then reformed anew in the day 





























Figure 29- Post-synapses structure is conserved in the glycerol-treated muscles three days after the 
injection. Three days after glycerol injection, TA muscles were dissected and cleared using the MYOCLEAR 
procedure and then immunostained with an anti-mouse mIgG antibody fluorophore-conjugated secondary 
antibody (mIgG, in green) and a fluorophore-conjugated α-BGT (AChR, in red) together with a DAPI to detect 
cell nuclei (in blue). Confocal tile-scans were then taken and analyzed. (A) 3D images of TA muscle injected 
with saline, in the magnification is possible to appreciate the post-synapse pretzel-shaped structure. (B) 3D 
images of TA muscle injected with glycerol, in the magnification is possible to appreciate a similar post-synaptic 
structure as the one detected in the control. Scale bar: 100μm. 





In this study three biological questions were answered:  
i) the possibility that a lower dose of glycerol, respect to the one commonly used, could 
still effectively induce a damage-recovery mechanism in the skeletal muscle;  
ii) how this kind of damage would affect the neuromuscular junction, as this aspect of 
muscle regeneration has never been investigated before in such model;  
iii) how a systemic stem cell-based treatment with adipose-derived mesenchymal stem 
cell could be beneficial for muscle and synapse recovery.  
Moreover, the application of the MYOCLEAR tissue clearing protocol on glycerol-treated 
muscles provided some interesting observations, although the number of experiments 
performed does not permit to reach any final conclusion on muscle damage and recovery, as 
well as regarding NMJ status, from a tridimensional point of view.  
5.1 Low glycerol dose leads successfully to muscle damage and 
subsequent recovery 
 
Regarding the first point, a lower amount of 50% glycerol solution (20 µl) was preferred to 
the amount normally used 50-100 µl in the literature (Mahdy 2018). This was decided 
considering that a higher amount could trigger some undesired secondary effects, such as 
acute kidney injury linked to rhabdomyolysis, and for technical reasons: glycerol viscosity 
causes the solution to drip from the injection site, without guaranteeing the same amount to be 
injected at every procedure, reducing the reproducibility of the experiments. 20 µl proved to 
be the maximum amount that was possible to inject in TA muscle without any leakage: any 
larger amount caused few droplets to not efficiently penetrate the tissue, and so making it 
impossible to assure the exact quantity of glycerol administered. As the results show, 20 μl 
was enough volume to successfully trigger a degeneration-regeneration cycle within the 
skeletal muscle. Fiber necrosis was present as early as eighteen hours after the injection, and 
necrotic myofibers were seen up to three days after the procedure. The levels of mIgG (and 
more in general of serum proteins) did not come back to normal levels until eleven days after 
the glycerol treatment. A similar trend was presented by the collagen I deposition, indicating 
intense muscle fibrosis at three days after the injection, which lasted in a milder form until 
eleven days. This indicated that, while glycerol led to an intense acute tissue necrosis and 
fibrosis at early timepoints, it lasted more than few days. Compared to models using higher 
volumes of 50% glycerol solution, the present less severe approach was able to avoid a late 
fibrosis phase, as it is usually reported (Mahdy et al. 2015). Simultaneous to the occurrence of 
the first necrotic fibers, loss of f-actin and dystrophin as markers for functional skeletal 
muscle fibers was observed. However, these proteins showed faster return to normal levels. 
To assess muscle regeneration, the amount of eMHC+ and/or center-nucleated myofibers 
(CNFs) as well as the overall total fiber counts were monitored. Fibers positive for eMHC 
were transiently increased between five and eight days post-injection in glycerol-treated 
muscles. Conversely, CNFs were also present at five days post glycerol injection but then 
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persisted in the treated muscles. Finally, reduced fiber numbers were only found at three days 
post glycerol and then rapidly returned to normal values. Overall, those findings defined the 
20 µl glycerol injection procedure as an efficient muscle damage/regeneration model causing 
injury to the tissue in the early phase with severe necrosis and fibrosis together with wide-
spread loss of functional muscle markers, followed by a regenerative response that ultimately 
leads to nearly complete recovery of the tissue in few days. Thus, this model presented the 
features in term of possibility to study muscle degeneration and recovery that deemed it apt to 
study possible therapeutic effects of ASCs application.  
 
5.2 Presynapses and postsynapses show a different sensitivity and 
recovery rate after glycerol-induced muscle damage 
 
As the NMJ recovery has never been studied in a glycerol-induced muscle damage model, its 
disruption and recovery were investigated. This showed that the pre- and postsynaptic 
compartments responded differently to the glycerol treatment. The postsynapses, while 
suffering a non-significant reduction over the investigated time period, showed a good degree 
of resilience against the effect of glycerol injection. A limited reduction in the number of 
AChR+ sites respect to the ones detected in the controls was observed only eleven days after 
the treatment. Conversely, while the percentage positive sites for VAChT among those 
positive for AChR (and then indicating the presence of co-localized presynapses at 
postsynaptic sites) was around 97% in the controls, it was significantly reduced in the 
glycerol treated muscles between three and eleven days after the glycerol injection. Indeed, 
VAChT was missing in around 60% of postsynaptic regions at three days post-injection, but 
then showed a continued partial recovery during the experimental period. Notably, 
postsynaptic sites were detected also in highly necrotic areas were the muscle was heavily 
damaged. This study cannot present formal proof that such sites were subsequently 
reinnervated, but the rather constant amounts of postsynapses detected throughout the 
experiment argue against a massive phase of ectopic synapse formation. Depending on the 
type of muscle damage model, different methods can target or affect different muscle 
compartments. Models based on mechanical, freeze or ischemic injury disrupted the plasma 
membrane effectively, but their effect on other elements was limited, as, for example, they 
left the extracellular matrix component intact for the most part (McMahan, Edgington, and 
Kuffler 1980; Slater and Schiaffino 2008; Anderson et al. 2017). In contrast, glycerol can lead 
to an extensive damage to the extracellular matrix (Mahdy et al. 2015; Hardy et al. 2016; 
Mahdy 2018). Since an intact extracellular matrix was previously described as an important 
prerequisite for both, postsynaptic preservation and guidance of motor axons to original 
synaptic sites (McMahan, Edgington, and Kuffler 1980), it was an interesting of this study 
that the loss of the extracellular matrix did apparently not strongly affect AChR postsynaptic 
maintenance, but resulted in a specific loss of presynaptic terminals. 
This effect could be ascribed to a partial matching between the pre- and postsynapse, resulting 
in an impaired synapse recovery. Such effect was reported when studying the role of laminins 
 Discussion - 57 - 
 
in regards to basal lamina perturbation and their effect of NMJs (Rogers and Nishimune 
2017).  
Although recovery of the presynapses was incomplete in our paradigm, it appeared to be 
faster than reported upon tourniquet (Tu et al. 2017) or nerve injury (Zainul et al. 2018). In 
both cases, complete presynaptic recovery was observed several weeks after the injury. One 
might speculate that the low amount of glycerol applied in the present study acted only 
locally, allowing a faster regrowth of motor neuron axons. Along with the characterization of 
muscle degeneration and regeneration, the glycerol model proved interesting also as a tool for 
studying synapse destruction and recovery. 
 
5.3 Adipose-derived mesenchymal stem cell systemic application as 
beneficial, although transient, effect on skeletal muscle and NMJ 
recovery 
 
The successful establishment of a glycerol-based muscle degeneration/regeneration model 
combined with its phenomenological characterization of muscle and NMJ behavior under 
these conditions, prompted to use this model for further investigation of possible therapeutic 
approaches. Adipose-derived stem cells (ASCs) were found to be interesting for possible 
clinical applications due to their differentiation capability (Timper et al. 2006; Radtke et al. 
2009; Deshpande, Grayson, and Spector 2015), their beneficial effects on other cell types 
involved in tissue regeneration, and their immunomodulatory properties. In this study, it was 
observed that systemic administration of ASCs in mice led to major differences in the muscle 
recovery profiles compared to mice treated with glycerol only. Firstly, in the presence of 
ASCs the levels of mIgG and collagen I in the glycerol-injected muscles were less affected 
than in the absence of ASCs, indicating a reduced severity of the initial degeneration. Also, 
the early detection of eMHC and diminished loss of presynaptic sites indicated an overall 
milder damage was present at three days post-injection. Secondly, however, the amount of 
mIgG, tissue fibrosis and center-nucleated myofibers were found to rise at eleven days after 
the treatment, suggesting the presence of a secondary damage or a differing regenerative 
phase. Fitting to this, also presynaptic NMJ recovery, which appeared to be faster at early 
time points upon ASCs treatment, was reduced eleven days after the treatment, were 
VAChT+ postsynaptic sites were reduced from around 80% at five days post-injection to 
around 57%. Although there is currently no formal proof, the observed alterations in the 
presence of ASCs could altogether be due to an immune cell mobilization in the muscle. 
Initially, immune cells could have dampened the disruptive effect of glycerol on the muscle 
fiber, thereby reducing myofiber necrosis and the intensity of inflammation. Subsequently, 
they could have affected muscle recovery via, for instance, an IL-6 dependent mechanism: 
Indeed, direct injection of mesenchymal/stromal cells was found to increase IL-6 levels by 
promoting the switch from M1 to M2 macrophages, thus also stimulating muscle stem cell 
activity (Arnold et al. 2007; Saclier, Yacoub-Youssef, et al. 2013; Mahdy 2018). Moreover, 
macrophage-secreted IL-6 has was shown to improve muscle regeneration (Meng et al. 2014). 
ASCs could also directly affect muscle tissue remodeling and muscle cell maturation by 
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actively migrating to affected muscles (Vieira et al. 2012). In this way, ASCs could enhance 
muscle regeneration (Rodriguez et al. 2005; Rybalko et al. 2017). Further, ASCs could 
influence muscle recovery through the release of paracrine factors which are involved in the 
modulation of the immune response and degeneration-regeneration processes. Recent studies 
on ASCs secretome therapeutic effect on an ischemic muscle damage model favor this 
hypothesis describing it as principal therapeutic mechanism (Mitchell et al. 2019; Figliolini et 
al. 2020). Figliolini, in particular, demonstrated how ASC-derived exosomes were able to 
promote vascular growth and tissue regeneration. Interestingly, the effect of adipose stem 
cell-derived extracellular vesicles in an ischemic model of muscle damage resulted in a less 
severe damage and in an increase in the expression of myogenic transcription factors, such as 
MyoD, myogenin and Myf5, along with Pax7. In support of a paracrine action of ASCs it has 
to be noted that we could not find ASCs in the treated muscles, thus excluding the possibility 
that ASCs had exerted their beneficial effects directly.  
 
 
Figure 30- Schematic summary of glycerol injection with or without ASCs systemic application on skeletal 
muscle tissue. The bars indicate the presence of markers as labeled, with the bar width indicating the amount. 
mIgG was used to quantify muscle necrosis and inflammation, while collagen I to quantify fibrotic tissue 
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deposition. The number of VAChT+ NMJs is referred to the percentage of colocalized VAChT signals on the 
total of the AChR+ signals detected. 
 
5.4 MYOCLEAR tissue clearing protocol proved to be promising for the 
three-dimensional investigation of neuromuscular junction structure 
and regeneration of glycerol-treated muscles. 
 
As already stated, three-dimensional investigation of samples can shed a new light on many 
biological processes. While, in principle, also classical two-dimensional analysis could 
provide the kind of data that can lead to a tri-dimensional reconstruction, tissue clearing and 
confocal microscopy can provide images that directly relate to biological information, in 
particular those regarding to localization, shape and size of definite structure. Further, by 
avoiding the virtual three-dimensional reconstruction phase from bi-dimensional images, 
optical tissue clearing strongly reduces possible mistakes or misinterpretation that might arise 
during the data processing phase. Yet, optical tissue clearing must tackle important 
challenges, particularly to find a compromise between reducing the natural opaqueness of 
biological tissue and preserving tissue-specific arrangement of markers and fluorescence of 
dyes. Thus, past and present protocols need to pay particular attention to (Richardson and 
Lichtman 2015; Silvestri et al. 2016): 
 
i) the biological questions posed and the methods chosen in order to answer 
them. This is linked to the fact that epitopes or structures of interest can be 
marked in different ways, with fluorophore-coupled toxins, dyes or using a 
combination of primary and secondary antibody. Not every tissue clearing 
method has the same effectiveness, and some are just not compatible with one 
or more staining protocols. 
 
ii) the kind of sample that need to be cleared. Tissues react differently based on 
their composition to clearing methods, and suitable protocols for the clearing 
of brain tissue could be completely ineffective when applied to a muscle. 
Moreover, the size of the sample has to be taken in account, as some 
techniques present limitations regarding the volume, as well as some 
microscopes. 
 
iii) technical limitations, as some tissue clearing protocols (in particular those 
based on active clearing) could require specific machinery or reagents not 
readily available. Also, while some methods can achieve optimal results in a 
matter of hours, other can require weeks to reach the stage where the sample is 
ready for imaging. 
 
Considering these three main factors, a custom-made method was developed starting from 
CLARITY in order to effectively locate and image NMJs in muscle tissue. This protocol, 
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termed MYOCLEAR, was successfully applied and tested, resulting in a complete 
segmentation (mostly automated, with only few additional signals that needed to be hand-
segmented) of the NMJs of murine extensor digitorum longus (EDL) muscles. It considered 
and solved the above-mentioned main issues of optical clearing protocols as follows: 
 
i) MYOCLEAR has been specifically designed to achieve the visualization of 
NMJs in the murine muscle with the use of fluorophore-coupled toxins (in this 
specific case, bungarotoxin).  
 
ii) it was tailored for its use on skeletal muscle, although its applicability to other 
organs or tissues is likely. 
 
iii) it uses mostly readily available materials and machinery, with also the 
possibility to build some of them “in-house”. 
 
Therefore, MYOCLEAR proved to possess several advantages respect to previous hydrogel-
based tissue clearing protocol. While other CLARITY-derived protocols showed a loss of 
fluorescence when using fluorophore-coupled  BGT (Milgroom and Ralston 2016; Zhang et 
al. 2018), MYOCLEAR was compatible with this dye, leading to a precise and defined 
localization and evaluation of NMJs within muscle tissue, allowing a precise quantification of 
the NMJ number along the whole EDL, by hand or semi-automated segmentation of whole 
mount images. Indeed, a murine EDL is normally composed of muscle fiber numbers ranging 
from 758 to 1435 (White et al. 2010; Bloemberg and Quadrilatero 2012). When counted from 
cryosections of our samples, the number of muscle fibers amounted to 1052±42 (mean ± 
standard deviation). Considering that each muscle fiber in an adult muscle is exclusively 
innervated by one NMJ (Krause 1863), the number of NMJ that was assumed to be present in 
the muscle analyzed was assumed to be in the same range as the one obtained from the 
muscle fibers count. Since MYOCLEAR revealed an average of 1082.3 ± 29.5 ±42 (mean ± 
standard deviation), it proved to detect next to all NMJs present in a murine EDL. Moreover, 
the quality of the signal allowed a morphological evaluation of NMJs structure, as conducted 
using a subset of parameters from those listed by Jones et al. (Jones et al. 2016). NMJs in 
muscles dissected from wild type and dystrophic (mdx) mice were analyzed measuring their 
area, perimeter, size (measured as the diagonal of the bounding rectangle) and fragmentation 
index. One interesting finding when those parameters were evaluated is that they significantly 
changed depending on the region of the tissue considered, particularly in regards of the 
fragmentation index in mdx muscles (Williams et al. 2019). Further, MYOCLEAR proved 
also to be applicable in combination with other dyes as well as primary and secondary 
antibodies, showing a considerable degree of flexibility that is not always granted by other 
tissue clearing protocols. In particular, immunostaining using antibodies for presynapses 
(VAChT), sarcomere (troponin I), sarcolemma (dystrophin) and extracellular matrix (collagen 
I) was demonstrated in this context. However, it has to be noted that only VAChT was visible 
beyond 500 μm within the tissue, while the other markers were detected only on a more 
 Discussion - 61 - 
 
superficial level, for about 200-300 μm. A possible improvement to achieve a better antibody 
penetration could arise from the use of additional techniques to grant a better penetration of 
the antibodies, such as stochastic electrotransport (S. Y. Kim et al. 2015; Nehrhoff et al. 
2016). A further limitation that was evident in MYOCLEAR was a strong autofluorescence in 
the blue to red fluorescence range, which was probably due to PFA-fixation induced 
chromophore formation (Baschong, Suetterlin, and Hubert Laeng 2001), limiting the possible 
options in matter of wavelengths available. Although that could be consider an issue, it can 
also prove useful since it allows to track individual muscle fibers. Moreover, it can be utilized 
to analyze some pathophysiological parameter, such as the presence of center-nucleated 
muscle cells, atrophic fibers, fiber splitting and other structural information. In order to detect 
at least two stained structures in the muscle, the dyes AlexaFluor647 and Draq5 were applied, 
since there is a slight shift in their emission wavelengths, in combination with spectral 
unmixing in the data-processing phase (Zimmermann et al. 2002). To avoid the occurrence of 
autofluorescence, it would be necessary to apply a different fixation protocol than the PFA 
incubation. In summary, MYOCLEAR is an advancement from previous CLARITY-based 
protocols, that is particularly tuned to permit the quantitative analysis of NMJ-related features 
in murine muscle whole mounts. 
With respect to the present study, MYOCLEAR was used to address fragmentation of NMJs 
upon glycerol as well as the correlation between loss of synapses and muscle damage. 
Although the experimental replicates were not enough to guarantee a satisfactory degree of 
certainty, some qualitative observations were made regarding muscle and postsynapse 
regeneration in the glycerol-induced muscle damage model. In particular, eMHC-positive 
muscle fibers and neuromuscular junction presence were investigated. Although a complete 
imaging of the whole tibialis anterior muscles was not achieved due to their size, a 
penetration of ~500 μm was observed. MYOCLEAR allowed to obtain some preliminary 
results on NMJ status and regenerating muscle fiber. 
First, regarding endplate regeneration, postsynapse fragmentation in the glycerol-treated 
muscles was not observed at the tested time-points, suggesting that postsynapse loss in 
glycerol-injected muscles occurred in an “all or nothing” mechanism: those synapses who 
were affected by the injection were completely disrupted and quickly eliminated from the 
tissue, while the remnants were unaffected, conserving their typical “pretzel-shaped” 
structure. Another possibility is the “upstream” hypothesis: glycerol effects could be severely 
detrimental to the nerve, hence causing the presynapses to disrupt, while any effect on the 
postsynapses would be more directly linked to the condition of the muscle tissue itself. When 
considering the distribution of the signal corresponding to eMHC presence, three points were 
made: 
 
i) eMHC antibody worked well when combined with MYOCLEAR, resulting in the 
efficient localization of regenerating muscle fibers. 
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ii) eMHC signal was not ubiquitous along the entire muscle fiber, suggesting that 
muscle regeneration in this model shows a certain degree of heterogeneity within 
the muscle. 
 
iii) Regenerating areas positive for eMHC did not present the autofluorescence in the 
blue to red wavelengths. 
 
Where detected, eMHC did not seem to be expressed along the entire fiber, suggesting that 
regeneration did not involve the entire myofiber at the same time, but was more localized or it 
or occurred in a “wave-like” manner.  
Finally, it was interesting to observe that the autofluorescence in the range of the blue-red 
wavelengths was pronounced in regenerating fibers compared to those negative for eMHC. 
Although in need of further confirmation, this suggests that the autofluorescence was present 
only in adult and/or undamaged myofibers. That could indicate that this phenomenon is linked 
to the interaction between PFA and one or more components present in the adult muscle 
tissue that are absent during the regeneration phase. Since muscle recovery is a multi-factorial 
complex process involving several muscle compartments (Tedesco, F. S., Dellavalle, A., 
Diaz-Manera, J., Messina, G., & Cossu 2010; Mahdy, Warita, and Hosaka 2016; Mahdy 
2018) from the cell nuclei with the expression of myogenic transcription factors to the 
extracellular space with the ECM remodeling, the identification of factors cause the PFA-
induced autofluorescence would need further studies and experiments. Though, their 
identification would prove desirable in order to avoid the PFA-induced autofluorescence and 
then increasing the wavelength availability in MYOCLEAR. 





Skeletal muscle is an important tissue in the organism, critical for movement and 
thermoregulation. Muscle tissue has a remarkable ability to regenerate, provided mainly by a 
subpopulation of muscle cells, referred to as satellite cells. A better knowledge of this 
recovery mechanism could help researchers and medical practitioners to develop therapeutic 
approaches to treat muscle-related diseases by pharmacological or stem-cell based means. 
Besides muscle cells and structure, also efficient neural transmission is critical for the organ 
function. This is provided by the neuromuscular junctions (NMJs), which are formed by the 
alignment of a motor neuronal pre-synaptic compartment and its muscular post-synaptic 
counterpart. In this thesis a glycerol-induced muscle degeneration/regeneration model was 
characterized and applied to address the regeneration of muscle and NMJs in the absence and 
presence of mesenchymal stem cells derived from adipose tissue (ASCs). In the absence of 
ASCs, glycerol injection led to early fiber necrosis, fibrotic tissue deposition and loss of actin 
and dystrophin. Between five and eight days after the glycerol injections, regeneration 
became evident with center-nucleated fibers and the expression of eMHC. Regarding the 
NMJs, their amount was diminished throughout the entire observation time of eleven days, 
with a slight recovery at five days post-injection. Notably, presynapses appeared to be more 
susceptible to glycerol damage than postsynapses and a complete recovery was not achieved 
within the observation window. In the presence of ASCs, the initial glycerol-induced damage 
was reduced compared to the glycerol-only model, but a recurrent inflammation and fibrosis 
was detected eleven days after the injection and the amount of regenerating fibers was higher. 
Further, in the presence of ASCs, early NMJs recovery was increased, but this was followed 
by a deterioration eleven days after the treatment. Those findings suggest that, while ASCs 
exert a beneficial effect in the first days after the treatment, a later inflammatory phase inflicts 
secondary muscle and NMJ degeneration. Since ASCs could not be detected in the affected 
muscles, it is likely that their effects on this tissue were rather due to release of signaling 
molecules than to direct engraftment in the muscle. 
In conclusion, a glycerol-based regeneration/degeneration paradigm was successfully 
established that allows to test properties of skeletal muscle and NMJs in the absence and 
presence of therapeutic means. This showed a differential sensitivity of pre- and postsynaptic 
portions to glycerol, as well as transient beneficial and latent inflammatory effects of systemic 
ASC application on skeletal muscle. 
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Figure 6- NMJ tripartite structure and the proteins involved in its development and 
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2016). ........................................................................................................................................ 12 
 
Figure 7- Transmission of the neural stimuli ending in muscle contraction. Acetylcholine  
(ACh) released in the synaptic cleft from the nerve terminal binds to its receptor (AChR), 
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tubules, extensions of the muscle fiber membrane containing a large number of ion channels 
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and AChR accumulation. Figure modified from Sanes and Lichtman (Sanes and Lichtman 
2001). 15 
Figure 9- NMJ fragmentation in a wild type (WT) and in a mdx mouse. The motoneuron 
is detected using an antibody against neurofilament (purple), the presynapse with one against 
synaptophysin (green) and the postsynapse by using a BTX coupled with a fluorophore. Is 
clear how the NMJ in the mdx mouse is fragmented respect to the healthy ones in the wild 
type. Scale bar: 10 μm. Figure from Pratt et al. (S. J. P. Pratt et al. 2015). ............................. 17 
 
Figure 10- Classification of clearing protocols. The most common taxonomy divides the 
different methods for tissue clearing in four groups, depending on which mechanism they 
applied to obtain tissue transparency. Figure from Silvestri, 2016 (Silvestri et al. 2016). ...... 18 
 
Figure 11- Representative figures of the results obtained with organic solvent-based 
tissue clearing protocols. Results on mouse brain transparency achieved with different 
organic solvent based methods (A, different methods as indicated in figure) and in the 
fluorescent signal preservation (B) of FDISCO respect to 3DISCO protocol (B, methods as 
indicated in figure, EYFP as endogenous yellow fluorescent protein). Figure adapted from Qi 
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Figure 12- CLARITY pipeline for a mouse brain. The tissue sample is perfused with a 
formaldehyde and acrylamide solution containing the thermal initiator as well. After the 
polymerization, the sample will be embedded in a meshwork of fibers preserving its structural 
and biological identity. A membrane lipid removal phase (passive or with the use of an 
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storage could be necessary. Image from Tomer et al. (Tomer et al. 2014). ............................. 20 
 
Figure 13- Results on NMJs visualization and segmentation in a murine EDL muscle 
with MYOCLEAR. EDL muscles from wild type (wt) and mdx mice were cleared using the 
MYOCLEAR protocol and then stained with BGT linked to a fluorophore to study 
postsynapse number, position, shape and structure. NMJs were successfully identified through 
the entire EDL (A,B) and their structure was clearly conserved, with mdx NMJs presenting 
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the fragmentation as expected ( A’, B’). When parameters describing NMJs structure were 
measured from different areas of the same muscle, and heterogeneity was found (C, E). 
Figure modified from Willliams et al. (Williams et al. 2019).................................................. 22 
 
Figure 14- Scheme showing the different cell types that could be obtained by adipose-
derived mesenchymal stem cells. Figure from Si, 2019 (Si et al. 2019). .............................. 23 
 
Figure 15-Successful glycerol injection in the tibialis anterior leads hindlimb 
contraction. In the upper panel (A), mice hindlimbs are showed before the treatment, in the 
lower panel (B) the same mice are showed less than a minute after 50% glycerol solution 
(right hindlimb) or saline (left hindlimb) injection. The contraction in the glycerol-treated 
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Figure 16- Scheme of the experimental design for the glycerol-induced muscle damage 
model. The days indicated start from the glycerol injection day (Day 0). 20 μl of 50% 
glycerol solution in saline solution were injected intra-muscle (i.m.). When adipose-derived 
stem cells (ASCs) treatment was applied, 1^106 cells resuspended in 100 μl of sterile PBS 
were systemically applied via tail vein (t. v.) soon after the glycerol injection was performed.  
Following dissection (Sample collection), TA muscles were snap-frozen in liquid nitrogen 
and embedded in OCT. Soon after cryosections from those muscles were obtained and 
subjected to immunofluorescence (IF) analysis in order to quantify both muscle damage and 
its recovery, along with the status of the endplates. When glycerol injection without the stem 
cell treatment was analyzed, samples were collected three, five, eight and eleven days after 
the injection. Where ASCs were applied, the days considered for sample collection were 
three, five and eleven days after the injection. ......................................................................... 28 
 
Figure 17- Scheme representing the different phases of the MYOCLEAR protocol. 
Hydrogel embedding phase last from day 2 to day 7, staining from day 8 to day 15, RI 
matching from day 16 to 17. It has to be considered that, where needed, a second washing 
step and dye incubation step are needed if primary and secondary antibodies are used, 
increasing the procedure time by 7 days. ................................................................................. 31 
 
Figure 18- Glycerol injection leads to structural damage to muscle fibers within 18 
hours from the treatment. After either glycerol or saline solution injection, TA muscles 
were harvested 18 hours after the treatment and snap-frozen. Subsequently, cryosections were 
obtained and stained with mouse immunoglobulin G antibody, phalloidin (both coupled with 
a fluorophore) and anti-dystrophin antibody.  Treated muscles (18 hrs p.i., on the right) show 
serum proteins uptake (mIgG) in the cytosolic space, indicating necrosis, along with loss of 
dystrophin and actin respect to the contralateral muscles (CTRL, on the left). Scale bar: 
100μm. ...................................................................................... Error! Bookmark not defined. 
 
Figure 19- Glycerol induced muscle damage is characterized by necrosis and loss of 
dystrophin and actin, followed by a transient expression of eMHC and the increase in 
center-nucleated fibers.  Representative optical sections of fluorescent signals as indicated 
(A), nuclear DAPI staining always shown in blue, mIgG in yellow, collagen I and eMHC in 
red, dystrophin in green, actin in grey. CTRL indicates muscle injected with saline three days 
post-injection, while the other panels show TA sections at three, five and eleven days after 
glycerol treatment. (B) Quantitative analysis of section areas positive for fluorescence signals 
of either mIgG, collagen I, dystrophin, or actin, or number of eMHC-positive fibers, as a 
function of days p.i. Box-Whisker plots show all individual data points as dots, the extensions 
of upper and lower quartiles in the boxes, the medians as horizontal lines in the boxes, and 
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maxima and minima as whiskers. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. (C-D) Quantitative 
analysis of fibers per muscle slice (C) or center-nucleated fibers (% of fiber number, D) as a 
function of days p.i. Box-Whisker plots show all individual data points as dots, the extensions 
of upper and lower quartiles in the boxes, the medians as horizontal lines in the boxes, and 
maxima and minima as whiskers. ** p ≤ 0.01, *** p ≤ 0.001. Scale bar: 100 μm .................. 35 
 
Figure 20- Glycerol induced muscle damage is characterized by necrosis and loss of 
dystrophin and actin, followed by a transient expression of eMHC and the increase in 
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nuclear DAPI staining always shown in blue, mIgG in yellow, collagen I and eMHC in red, 
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images of the localization of AChR (in green) and VAChT (in red) and their overlay in TA 
muscle cross section (A) at different timepoints (The sham procedure three days after the 
injection indicated as sham, the other timepoints as in the amount of days post-injection 
(p.i.)). Scale bar: 100μm. Quantitative analysis of AChR+ sites (B) present per cryosection 
and percentage of how many of them were positive for VAChT as well (C). Shown is mean ± 
SEM (n = 3 muscles). * p ≤ 0.05, ** p ≤ 0.01. ........................................................................ 41 
 
Figure 22- AChR+ VAChT- sites were identified in highly necrotic areas as well as in 
unaffected regions. Postsynaptic sites were found in necrotic areas of the muscle. When 
considered if that could be the reason they were negative for VAChT, negative postsynaptic 
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Figure 23- ASCs systemic application leads to mIgG infiltration, enhanced eMHC basal 
expression and increase in the center-nucleated fibers. Representative optical sections of 
fluorescent signals as indicated (A), nuclear DAPI staining always shown in blue, mIgG in 
yellow, collagen I and eMHC in red, dystrophin in green, actin in grey. CTRL indicates 
muscle injected with saline three days post-injection, while the other panels show TA sections 
at three, five and eleven days after glycerol treatment. (B) Quantitative analysis of section 
areas positive for fluorescence signals of either mIgG, collagen I, dystrophin, or actin, or 
number of eMHC-positive fibers, as a function of days p.i. Box-Whisker plots show all 
individual data points as dots, the extensions of upper and lower quartiles in the boxes, the 
medians as horizontal lines in the boxes, and maxima and minima as whiskers. * p ≤ 0.05, ** 
p ≤ 0.01, *** p ≤ 0.001. (C-D) Quantitative analysis of fibers per muscle slice (C) or center-
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individual data points as dots, the extensions of upper and lower quartiles in the boxes, the 
medians as horizontal lines in the boxes, and maxima and minima as whiskers. ** p ≤ 0.01, 
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fluorescent signals as indicated (A), nuclear DAPI staining always shown in blue, mIgG in 
yellow, collagen I and eMHC in red, dystrophin in green, actin in grey. CTRL indicates 
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Figure 25- ASCs enhance recovery of presynapses at early stages, but such effect is not 
present at late time point. As soon as TA muscles were injected with either saline or 50% 
glycerol solution, mice were injected via tail-vein with ASCs. TA muscles were then 
harvested and immediately snap-frozen three, five or eleven days after the injection (days 
p.i.). After cryosectioning, muscle sections were stained with αBGT (marking AChR) and 
antibodies against VAChT to label post- and presynaptic portions of NMJs, respectively. 
Cryosections were then analyzed with confocal microscopy. (A) Representative images of 
fluorescence signals as indicated, AChR in green, VAChT in red, in overlay images yellow 
indicates the colocalization of both signals. Saline-injected muscles at 3 days p.i. indicated as 
CTRL, while the other panels show representative images from glycerol-injected muscles at 
three, five and eleven days post-injection. Scale bar: 100µm. (B-C) Quantitative analysis of 
AChR+ post-synaptic sites present per section (B) and of VAChT+ NMJs (as percentage of 
VAChT+ structure, C) as a function of days after the treatment. Shown is mean ± SEM (n = 3 
muscles). * p ≤ 0.05, ** p ≤ 0.01. ............................................................................................ 48 
 
Figure 26-Integration of systemically injected ASC into muscle is not detectable by 
immunofluorescence. Isolated human ASC and mouse TA muscle sections taken five days 
post injection of either saline or glycerol (indicated) were stained with DAPI and an anti-
human Ku80 antibody against DNA and human nuclei, respectively. (A) Representative 
confocal micrographs showing fluorescence signals of DAPI and human Ku80 in blue and 
green, respectively. (B) Quantitative analysis of the percentage of human Ku80+ signals 
found in DAPI+ nuclei. ............................................................................................................ 50 
 
Figure 27- eMHC is not present in saline-injected muscles and postsynaptic structure is 
preserved. Five days after saline injection, TA muscle was dissected and cleared using the 
MYOCLEAR procedure and then immunostained with anti-eMHC antibody (subsequently 
coupled with a fluorophore-conjugated secondary antibody) and a fluorophore-conjugated α-
BGT. (A) 3D images of saline-injected TAs. Autofluorescent background (Autofluo) signal in 
the 488 nm channel was used to highlight the muscle structure and is shown in green, eMHC 
in red and presence of AChR in white. No constitutive expression of eMHC was observed in 
this sample. Scale bar: 1 mm. (B) Magnification of the postsynaptic structures showed the 
preservation of their classical pretzel-like shape, without any sign of fragmentation. ............ 52 
 
Figure 28- eMHC expression in glycerol-injected TA, postsynaptic structure is 
preserved. Five days after glycerol injection, TA muscle was dissected and cleared using the 
MYOCLEAR procedure and then immunostained with anti-eMHC antibody (subsequently 
coupled with a fluorophore-conjugated secondary antibody) and a fluorophore-conjugated α-
BGT. (A) 3D images of saline-injected TAs. Autofluorescent background (Autofluo) signal in 
the 488nm channel was used to highlight the muscle structure and is shown in green, eMHC 
in red and presence of AChR in white. Strong presence of eMHC was observed in this 
sample. Scale bar: 1mm. (B) Magnification of the postsynaptic structures showed the 
preservation of their classical pretzel-like shape, without any sign of fragmentation. ............ 53 
 
Figure 29- Post-synapses structure is conserved in the glycerol-treated muscles three 
days after the injection. Three days after glycerol injection, TA muscles were dissected and 
cleared using the MYOCLEAR procedure and then immunostained with an anti-mouse mIgG 
antibody fluorophore-conjugated secondary antibody (mIGg, in green) and a fluorophore-
conjugated α-BGT (AChR, in red) together with a DAPI to detect cell nuclei (in blue). 
Confocal tile-scans were then taken and analyzed. (A) 3D images of TA muscle injected with 
saline, in the magnification is possible to appreciate the post-synapse pretzel-shaped structure. 
(B) 3D images of TA muscle injected with glycerol, in the magnification is possible to 
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appreciate a similar post-synaptic structure as the one detected in the control. Scale bar: 
100μm. ...................................................................................................................................... 54 
 
Figure 30- Schematic summary of glycerol injection with or without ASCs systemic 
application on skeletal muscle tissue. The bars indicate the presence of markers as labeled, 
with the bar width indicating the amount. mIgG was used to quantify muscle necrosis and 
inflammation, while collagen I to quantify fibrotic tissue deposition. The number of VAChT+ 
NMJs is referred to the percentage of colocalized VAChT signals on the total of the AChR+ 
signals detected. ....................................................................................................................... 58 
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